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CHAPTER l. RATIONALE AND AIM OF THE STUDY 
At present, end-stage hepatic disease can only be 
cured by orthotopic liver transplantation. As a pediatric 
surgeon the writer of this thesis was interested in the 
problems that hamper the development of pediatric 
orthotopic liver transplantation and particularly in the 
problem of the shortage of appropriately sized donor 
livers. 
Matching of the size of the donor liver with the size 
of the recipient liver has been a general principle in 
clinical orthotopic liver transplantation,l-6 and 
insurmountable problems have been encountered when livers 
that were too large were transplanted.7,8 Matching for 
size is a special problem in pediatric orthotopic liver 
transplantation. The weight of the liver of the full-term 
infant is doubled at 2 years and tripled at 3 years; at 5 
years it has increased 6 times, and the liver of an 
adult, weighing approximately 1500 gr, is 12 to 13 times 
as large as that of the newborn.9 Because of these 
age-related differences in the size of the liver, 
age-matched donor livers are required in pediatric liver 
Pediatric donor livers, transplantation. 
constitute only a small part of the total donor 
however, 
poo1. 10 
Moreover, adult candidates for liver transplantation 
compete for these livers, 4 , 11 which aggravates the 
problem of the shortage of donor livers in pediatric 
liver transplantation. This competition will increase 
further when heterotopic auxiliary transplantation 
becomes a truly therapeutic procedure. The group of 
pediatric liver transplantation candidates younger than 6 
years of age is the most severely affected by the 
ll 
shortage of age-related donor livers. 6 
The use of livers from anencephalic newborns in these 
children is theoretically attractive, 2 ' 4 and there is one 
report of a case in which such a liver was used in an 
adult recipient. 7 However, this potentially large pool of 
donor livers - the incidence of anencephaly being 1 in 
1,000 births 12 - is likely to decrease as a result of 
increasing prenatal diagnosis of the condition and the 
associated increasing abortion rate of these fetuses. 
Moreover, it is not certain whether successful 
transplantation of such livers is possible. 
An alternative solution for the problem of the 
discriminatory role of the size of the donor liver in 
recipient selection for orthotopic liver transplantation, 
would be the use of only part of a donor liver. The left 
lateral segment of an adult human liver, which accounts 
for about 25% of the total liver weight,9 could be used 
for this purpose. Survival after removal of all but that 
segment of the liver has proven to be possible in 
patients requiring hepatic tumor surgery.l3 
The experimental study reported here was performed to 
assess in dogs the feasibility of replacing the native 
liver by part of a donor liver. 
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CHAPTER 2. THE NEED FOR LIVER TRANSPLANTATION 
2.1. Treatment of terminal liver failure 
The liver has so many different functions, for example 
synthesis, storage, homeostasis, and detoxification, that 
it is highly unlikely that an effective artificial liver 
will become available during the next few decades.! Even 
the results of short-term support of the acutely failing 
liver provided by various methods such as exchange 
transfusion, plasmapheresis, total body washout, cross 
circulation, 
resin or 
hemodialysis, 
Although 
extracorporeal liver perfusion, exchange 
activated charcoal hemoperfusion, and 
have been disappointing. 2 -4 
liver transplantation is not generally 
accepted as a form of short-term support in cases of 
acute liver failure, because of the usually uncertain 
prognosis, the poor surgical risk, the possibility of 
transmission of the original disease to the graft, and 
the possible interference with the regeneration of the 
native liver tissue,4-6 this method has been the most 
successful in prolonging survival or allowing recovery 
from experimentally induced acute liver failure of 
various origins. 7-11 
In chronic end-stage hepatic disease, the only chance 
of cure and long-term survival is provided by liver 
transplantation. 
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2.2. The need for pediatric liver transplantation in The 
Netherlands 
THE INCIDENCE AND FATALITY OF BILIARY ATRESIA IN THE 
NETHERLANDS 
-An Indicator for the Need for Pediatric Liver 
Transplantation-
N.M.A. Bax and J.C. Molenaar. 
From the Department of Pediatric Surgery, University 
Children•s Hospital, Rotterdam, The Netherlands. 
Published in J Jpn Soc Pediatr Surg 8:1023-1027, 1982. 
Reproduced by permission. 
Summary 
Two hundred of the 310 children who died in The 
Netherlands over a 10-year period due to a liver or 
biliary-tract condition could have been potential 
candidates for liver transplantation. Seventy-five 
percent of these candidates had biliary atresia, the 
incidence of which is estimated to be 0.93 per 10,000 
live births in this country. At the current annual birth 
rate of 180,000, 16 to 17 new cases may be expected each 
year and 13 to 14 of these patients will die if the 
results of treatment remain unchanged. Even if the high 
Japanese standard of treatment can be reached, a 
considerable number of patients with biliary atresia will 
progress to end-stage hepatic disease. The results of 
liver transplantation achieved in these patients have 
been poor, which 
experimental work. 
underlines 
20 
the need for further 
Introduction 
This 
idea 
retrospective study was undertaken to obtain 
of the number of pediatric patients 
a rough 
in The 
Netherlands annually who could be considered candidates 
for liver transplantation. 
Results 
Mortality due to liver and biliary-tract conditions in 
The Netherlands and potential candidacy for liver 
transplantation. 
According to the Netherlands Central Bureau for 
Statistics, at least 310 children younger than 15 years 
of age died in The Netherlands between 1969 and 1978 as 
the result of a liver or biliary-tract condition {Table 
1) • 
Table 1. Mortality due to liver and biliary-tract conditions in three pediatric age groups in 
The Netherlands in the period 1969- 1978. (Netherlands Central Bureau for Statistics). 
<1 year 1-3 years 4-14 years total % 
c c c c 
injury (864) 0 10 22 32 10.32 
2 primary tumors ( 155.0; 155.1) 8 12 8 28 9.03 ( 211.5; 230.5) 
3 infectious hepatitis (070) 3 5 3 11 3.53 
4 acute and subacute necrosis (5701 3 2 2 7 2.25 
5 cirrhosis (571 I 18 13 17 48 15.48 
6 congenital anomalies (751.6) 99 46 10 155 50.00 
7 others (573; 576) 18 6 5 29 9.35 
total 149 94 67 310 100.00 
*:=international classification of diseoses14. 
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It is unlikely that the children whose death was due 
to an injury would have been potential candidates for 
liver transplantation, because in these patients 
bleeding, and less frequently biliary peritonitis, are 
the main causes of death rather than liver failure.l-3 
Liver transplantation for primary hepatic malignancy 
not treatable by partial hepatectomy, has not been very 
successful. Calne reported a 60% recurrence rate in 
patients grafted for primary hepatoma, and Starzl found 
an 89% recurrence rate in patients who survived beyond 3 
months. 4 ' 5 The limited experience with liver 
transplantation for primary malignancy of the liver in 
children has not shown better results. All 3 children 
with a hepatoma who were transplanted by Starzl died, one 
after 143 days due to massive metastases and two after a 
little more than a year due to tumor recurrence.6 
In spite of the high fatality rate associated with 
fulminant hepatic failure, this condition is generally 
not accepted as an indication for liver 
transplantation.7,8 Auxiliary liver transplantation 
has, however, had the most success in prolonging survival 
or allowing recovery 
liver failure.9-ll 
in experimentally induced 
Clinical experience with 
acute 
liver 
transplantation in acute liver failure has been too 
limited to provide a basis for definite conclusions, and 
further experimental 
logistical problem 
work is badly needed. The major 
posed by the need to find an 
appropriate cadaveric donor organ within the very brief 
time span in which such patients are legitimate 
candidates for liver transplantation is not likely to be 
solved in the foreseeable future. 12 
Chronic end-stage hepatic disease is considered to be 
the main indication for liver transplantation.l3 Roughly 
two-thirds of the children who died in The Netherlands 
in the period 1969-1978 due to a liver or biliary-tract 
condition had chronic end-stage hepatic disease and could 
have been potential candidates for liver transplantation. 
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Seventy-five percent of these patients had a congenital 
anomaly of the hepato-biliary system. Because most of the 
congenital anomalies listed under Nr. 751.6 of the 
International Classification of Diseases 14 are compatible 
with long-term survival, the children who died were in 
all probability suffering from biliary atresia. 
Obviously, the incidence and fatality rate of this 
condition in The Netherlands will to a great extent 
determine the yearly number of pediatric patients who 
might be considered candidates for liver transplantation 
in any given year. 
The fatality rate of biliary atres·ia in the University 
Children 1 s Hospital in Rotterdam, The Netherlands. 
To obtain an idea of the fatality rate associated 
with biliary atresia in The Netherlands, the results of 
treatment in one leading center for pediatric surgery 
were analysed. Thirty- four children with biliary atresia 
were treated in the period 1970-1979 in the University 
Children's 
hypoplasia 
excluded. 
Hospital 
of the 
in Rotterdam. Cases of what is called 
intrahepatic biliary system were 
Eleven patients underwent an exploratory laparotomy 
only, and all these patients died. Of the remaining 23 
patients in whom a bilio-digestive anastomosis was 
established, six survived, the follow-up period ranging 
from 4 to 12 years, and 5 of these 
free of jaundice. Therefore,the 
amounted to 82%. 
patients have remained 
over-all fatality rate 
The incidence of biliary atresia in The Netherlands. 
On the assumption that the over-all results of 
treatment of 
throughout The 
did not differ 
biliary atresia were 
Netherlands in the period 
much the same 
1970-1979 and 
substantially from the results obtained in 
23 
the period 1969-1978, the total number of new patients 
with biliary atresia in The Netherlands in the latter 
period can be estimated to have been 189; of these, 155 
(82%) died and 34 (18%) survived. 
In the same period, 2,012,600 children were born, and 
therefore the incidence of biliary atresia can be 
estimated to be 0.93 per 10,000 live births. At an actual 
annual birth rate of 180,000 in The Netherlands, 16 to 17 
new cases per year may be expected and 13 to 14 of these 
children will die if the results of treatment are not 
improved. 
Discussion 
It has long been believed that biliary atresia is more 
common in Japan than in other countries and that this 
explains the greater 
that country. 15 , 16 
substantiated 17 
attention given to the condition in 
This 
and the 
premise 
limited 
has 
data 
never been 
available, 
including the present results, have not furnished any 
proof that the 
Japanese. 22 - 25 
incidence is greater among the 
Some improvement in the fatality rate associated with 
biliary atresia in The Netherlands can be expected now 
that Kasai's approach 26-2 9 has been generally accepted 
as the standard method of treatment. Moreover, it is 
slowly being recognized that the age at operation is an 
extremely important factor for the ultimate prognosis. 
Most important perhaps is the growing awareness that the 
Japanese treatment results are far better, and this is a 
challenge to improve the results elsewere. Sawaguchi 
reported a one-year survival rate of 48% and a five-year 
survival rate of 24% in a series of 117 patients treated 
at the National Children's Hospital in Tokyo in the 
period 1967-1973. Three other patients died 5, 7, and 10 
years postoperatively. 21 , 30 Of the 55 patients treated by 
Kasai at the Tohoku University Hospital in Sendai in the 
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period 1971-1976, 89% had postoperative bile flow but 
only 49% were alive and free of jaundice in 1977.18 ,29 
Better results are obtained in the group of children 
operated on before the 60th day of life, especially in 
the more recent series, in terms of not only 
postoperative bile excretion but also the achievement of 
a jaundice-free state. In these children cholangitis is 
much less of a problem and the 5 year jaundice-free 
survival seems likely to improve.l9- 21,29 
In spite of major advances in the treatment of biliary 
atresia a considerable number of patients still die of 
end-stage hepatic disease, even in Japan. Theoretically, 
liver transplantation after an unsuccessful Kasai 
procedure remains an attractive approach. In patients 
with end-stage hepatic disease based on biliary atresia, 
Starzl favors removal of the native liver not only 
because orthotopic nonauxiliary grafting has been more 
successful than heterotopic auxiliary grafting but also 
in view of the high incidence of incidental malignancies 
present in the native liver.6 Furthermore, in view of the 
high incidence of recurrent cholangitis after an 
unsuccessful Kasai procedure, the native liver should be 
considered an infected organ and should be removed. 
However, 
transplantation 
poor. Of the 48 
March 1963 and 
the results of orthotopic liver 
in children with biliary atresia are 
children transplanted by Starzl between 
January 1978, only 33% survived for one 
year and only 17% were alive at the time of publication. 
The bilio-digestive anastomosis in these 
been a major problem.6 The absence 
extrahepatic biliary tract precludes a 
children has 
of a normal 
choledocho-
choledochostomy and this may be one of the reasons why 
children transplanted for other reasons did distinctly 
better. 
Further experimental work is badly needed in order to 
make liver transplantation in children with end-stage 
hepatic disease a more acceptable procedure. 
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CHAPTER 3. MODES OF LIVER TRANSPLANTATION 
3.1. Classification and nomenclature 
Livers or liver fragments have been transplanted in 
many different ways, which can be classified according 
to: 
a. The vascularization of the graft 
In free grafting no anastomoses are performed.! A 
special form of free grafting is hepatocellular 
transplantation, in which suspensions of liver cells are 
injected into the bloodstream, the peritoneal cavity, or 
a solid organ.2-7 
In collaterally vascularized grafts, the autochthonous 
blood supply is severed after a collateral circulation 
from adjacent organs has been established. 8 -ll 
Arterialization of hepatic segments to be auto-
transplanted has also been performed by direct vascular 
implantation.12 
In classic liver transplantation, the graft is 
vascularized by direct vascular anastomoses. 
b. The origin of the graft 
In autotransplantation the graft is taken from and re-
introduced into the same individual. An allo- or 
homograft is a graft taken from a different individual of 
the same species. A xenograft is a graft taken from a 
different species. 
c. The functional destination of the graft 
Depending on whether the native liver has been removed 
or left in situ, the graft will have to function in a 
nonauxiliary or an auxiliary way. 
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d. The anatomical destination of the graft 
In orthotopic transplantation the graft is placed in 
an anatomical position which usually but not necessarily 
requires total removal of the native liver.l3-16 In 
heterotopic transplantation the graft is placed in a 
nonanatomical position. 
3.2. Discussion 
Only a few modes of liver transplantation have 
survived in experimental practice, and even fewer have 
reached the stage of clinical application. 
3.2.1. Vascular supply and biliary drainage of the graft 
Experience showed that a liver graft, even a small 
one, needs a direct anastomotic blood supply as well as 
biliary 
of small 
drainage, and this situation has hampered the use 
liver fragments for transplantation. In 
hepatocellular transplantation, no anastomoses have to be 
performed, but the biliary drainage system of the native 
liver must be intact. Promising results have been 
obtained experimentally with this mode of liver 
transplantation, but its value for the treatment of acute 
liver failure and hepatic enzyme defects in man remains 
to be proven. 
3.2.2. The origin of the graft 
Autotransplantation is of interest for the study of 
the fate of a graft in the absence of rejection. The 
procedure is, however, a difficult one, because of the 
relative shortness of the vascular pedicles. Moreover, 
extensive manipulation of the liver is hard to avoid and 
liver damage is likely to occur. It is therefore hardly 
surprising that the experimental results have been 
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poor.l7-22 This mode of transplantation is unsuitable 
for the study of techniques for long-term preservation of 
the liver, at least when the whole liver is to be 
autotransplanted, because the duration of the anhepatic 
phase and of the period during which the organ must be 
preserved is of course the sarne. 17 The use of xenografts 
has been abandoned because of the 
uncontrolable immunological reactions. 23-2 5 
severe and 
For clinical 
liver transplantation only allografts are used at 
present. 
3.2.3. Heterotopic auxiliary transplantation 
This mode of liver transplantation is theoretically 
very attractive. Since the native liver does not have to 
be removed, the surgical procedure is much less hazardous 
and the graft can be removed if it fails or the native 
liver recovers. Considerable attention has been paid to 
this mode of liver transplantation, but the results have 
been much less satisfactory than those obtained with 
orthotopic liver transplantation, both experimentally and 
clinically. 27 - 30 
3.2.3.1. The problem of graft atrophy 
According to the original technique developed by Welch 
and Goodrich, the donor suprahepatic caval vein was 
anastomosed end-to-end with the proximal part of the 
transected recipient infrarenal caval vein and the donor 
portal vein end-to-end with the inferior part of the 
transected recipient infrarenal caval vein. The donor 
intrahepatic caval vein was closed. The graft was also 
supplied with arterial blood and biliary drainage. 31 , 32 
After the introduction of immunosuppressive drugs 
early in the Sixties, some dogs in which Starzl et al. 
used this technique survived for at least a few weeks. At 
autopsy, however, the grafts showed marked atrophy and a 
greater degree of cellular invasion and hepatocyte loss 
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than was seen in orthotopic grafts. 33 This observation, 
confirmed by others,34,35 gave a rise to an 
extensive discussion concerning the etiology of the 
atrophy, and most of the hypotheses put forward at that 
time, on such points as dependency of the graft on portal 
blood and functional competition between the native liver 
and the graft, are still topical. 
3.2.3.2. Modifications of the venous anastomoses 
The caval anastomosis 
Sicular et al. introduced the end-to-side anastomosis 
between the donor suprahepatic and the recipient 
intrahepatic caval vein.36 Bengoechea-Gonzalez et al. 
used the donor intrahepatic caval vein for this 
anastornosis.37 In one series of experiments, Marchioro et 
al. interposed the donor retro-hepatic caval vein between 
the transected ends of the recipient infrarenal caval 
vein. 38 Transplanting part of the donor liver 
heterotopically, van der Heyde et al. resected most of 
the donor retrohepatic caval vein, leaving only a patch 
for the subsequent end-to-side anastomosis.39 Although in 
the rat the donor intrahepatic caval vein has been 
considered superior to the donor suprahepatic caval vein 
for the end-to-side anastornosis,40, 4l the latter vessel 
seems preferable in larger animals. 42 At least in dogs, 
the hepatic veins enter the caval vein in a cranial 
direction at a narrow angle, and this situation makes the 
use of the donor intrahepatic caval vein for the 
end-to-side anastomosis with the recipient intrahepatic 
caval vein hemodynamically unfavorable. Le Compt et al. 
and Jerusalem et al. have underscored the importance of 
having a venous outflow of the donor liver as close to 
the heart as possible, and referred in this connection to 
the work of Moreno et al.43-45 
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The portal anastomosis: quantity versus quality of the 
venous supply~ 
Much experimental work on the portal vein anastomosis 
has been published. Hagihara et al. removed the spleen 
and established an end-to-end anastomosis between the 
donor portal and recipient splenic veins. 46 Mehrez et al. 
did the same, but also constricted the recipient portal 
vein to promote portal flow through the graft. 47 In an 
impressive series of experiments, Marchioro et al. showed 
that graft atrophy could be 
not by an 
splanchnic 
incomplete) 
venous blood 
prevented by 
diversion of 
flow through 
a complete (and 
the nonhepatic 
the graft. 38 
Halgrimson et al. showed that atrophy of a graft provided 
with systemic venous blood through the portal vein, could 
be partially prevented by a portocaval shunt. 48 In split 
transposition experiments in which one part of the liver 
received all of the nonhepatic splanchnic venous blood 
and the other part received systemic venous blood, 
Marchioro et al. found atrophy of the part receiving 
systemic venous blood even though the flow to both parts 
had been equal.49 In a classic Welch-Goodrich model, 
Daloze et al. studied the venous flow through the graft 
and through the native liver and found no difference.SO 
In experiments in which the native liver received 
systemic venous blood and the graft nonhepatic splanchnic 
venous blood, atrophy was still more pronounced in the 
graft.Sl 
The discussion on the relative importance of the flow 
and the quality of the venous blood continued, and liver 
transplantation experiments in which 
arterialized tended to 
the donor 
support 
portal 
the flow vein was 
theory. 52 Splanchnic flow diversion experiments in dogs 
led Starzl et al. to conclude that liver lobes receiving 
blood from the pancreatic, gastroduodenal, and splenic 
veins did better than the liver lobes receiving blood 
from the bowel, and that the hepatotrophic factors are 
pancreatic in origin.53 However, Child et al. and later 
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Malt stated that direct perfusion of the liver with 
portal blood is not 
Hess 
essential 
et al. 
for hepatic 
regeneration. 54 , 55 concluded from 
transplantation experiments in rats that the survival of 
the graft is determined by the total liver flow in 
combination with the functional state of the liver rather 
than by the quality of venous blood.56 
3.2.3.3. The concept of functional competition 
It has long been recognized that ligation of one of 
the hepatic bile ducts causes atrophy of the 
corresponding liver lobe and hypertrophy of the other 
lobes. 57 The theory concerning functional competition was 
put forward by Schalm et al. in 1956,58 and was extended 
to the 
1966. 59 
field of auxiliary 
As early as 1965, 
liver transplantation in 
Thomford et al. reported that 
removal of the native liver had a protective effect on 
the heterotopic liver. 34 Many experiments followed in 
which the 
diversion 
native liver was handicapped by 
and bile-duct ligation.39,60-65 
portal blood 
The results 
were, however, difficult to evaluate in view of the 
differences between the models, the unpredictable effect 
of rejection, and the inability to achieve consistent 
long-term survival. 
3.2.3.4. Intrinsic hepatic growth control factors 
The factors that regulate the size of a normal liver 
are still poorly understood. If there really is a growth 
inhibiting substance in nonregenerating liver tissue, as 
has been 
auxiliary 
suggested, it is not surprising that the 
liver cannot maintain its size because 
reparative regeneration of the damage in the graft due to 
ischemia and rejection is inhibited by the native liver. 
However, the presence of such an intrahepatic inhibitory 
substance remains controversial.66 
In contrast there is increasing evidence that 
regenerating liver tissue contains a factor that augments 
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a regenerative response. It has been shown in dogs that 
intraportal injection of a cytosol extract from 
regenerating liver reverses the atrophy caused by a 
complete portocaval shunt 67 and promotes regeneration 
after partial hepatectorny.66 The factor involved here was 
neither glucagon nor insulin.66,67 No growth-promoting 
effect was seen when these extracts were injected into 
the systemic venous circulation 
cavity. 66 Whether such extracts 
or 
are 
the peritoneal 
effective when 
infused into the portal vein of nonregenerating livers, 
is still uncertain.66 
The existence of a growth-inhibiting substance in 
normal nonregenerating liver tissue and of a 
growth-stimulating substance in regenerating liver tissue 
could explain why the normal native liver has to be 
handicapped to prevent atrophy of the auxiliary liver. 
3.2.4. Orthotopic nonauxiliary transplantation 
Orthotopic liver transplantation is the only mode for 
which large-scale clinical trials have been performed. 
Since the first efforts to replace a human liver in 
1963,68 more than 350 orthotopic transplantations have 
been carried out by the two leading teams in the world. 
The over-all results, although better than the results 
achieved with other modes of liver transplantation, have 
been poor until rather recently. 6 9 Smaller series of 
clinical orthotopic liver transplantations have been 
reported by other teams. Of particular interest in The 
Netherlands is the clinical liver transplantation program 
started by the Groningen University Hospital in 1979. By 
the end of 1983, Krorn and his team had transplanted 32 
patients. 70 
The results obtained in clinical orthotopic liver 
transplantation are presented in Chapter 5. 
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3.3. Comments 
Three modes of liver transplantation continue to be of 
clinical interest. The hepatocellular mode, however, 
biliary drainage requires 
therefore 
an intact 
unsuitable for patients with 
system and is 
biliary atresia. 
The heterotopic auxiliary mode has not lost its 
theoretical attraction, but the results have been poor, 
both experimentally and clinically. Moreover, even if the 
problem of graft atrophy were solved, the logistics of a 
supply of appropriately sized donor organs would hamper 
clinical application. The experimental study reported in 
this thesis can therefore be seen as a first step toward 
the development of a heterotopic auxiliary model making 
use of partial livers. After this experimental study, 
liver transplantation research was continued in the same 
center and a heterotopic auxiliary model using partial 
livers was designed, and gave promising results. 71 The 
results of these experiments indicate that graft atrophy 
can be prevented and that long-term graft survival can be 
obtained by avoiding and controlling rejection. 
At present, only the orthotopic nonauxiliary mode has 
proven to have unequivocal value in human medicine. 
Furthermore, as pointed out in section 2.2, it seems wise 
to remove the native liver in children with biliary 
atresia at the time of transplantation, because once a 
hepatic porto-enterostomy has been performed the native 
liver should be considered a potentially infected organ, 
and also because incidental carcinomas have been found in 
the native livers of patients with biliary atresia. In 
addition, removal of the native liver creates space for 
the insertion of the graft. 
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CHAPTER 4. PROBLEMS ASSOCIATED WITH CLINICAL ORTHOTOPIC 
LIVER TRANSPLANTATION 
4.1. The donor liver 
4.1.1. Shortage of donor livers 
Potential cadaveric liver donors outnumber by far the 
eligible recipients, and theoretically there should be no 
shortage.l-3 The actual procurement of donor livers has, 
however, been a major problem.2,3 Moreover, as pointed 
out in Chapter 1, the size matching between donor and 
recipient is obligatory and this means a greater demand 
for small donor livers. Because of the prevailing 
shortage of appropriately sized donor livers, both of the 
leading transplantation teams in the world have 
transplanted across a positive cytotoxic crossrnatch. 4 - 6 
One of these teams has even transplanted despite 
blood-group incompatibilitya5,6 For the same reason and 
because of the time constraints on liver preservation, 
tissue matching has never had a fair trial. 4 - 6 The use of 
tissue-matched livers would, however, require an enormous 
donor poo1. 7 
4.1.2. The discriminatory role of size of the donor organ 
in recipient selection 
This problem forms the main subject of the present 
thesis, and has been discussed in Chapter 1. In 1981, 
Starzl and his team used only 30 liver grafts among 176 
available organs. The inability to use the other 146 
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livers was usually due to a disparity in size between the 
donor and recipient, or incompatibility of the donor and 
recipient blood groups, or saturation of the Pittsburgh 
facilities for liver recipients. 6 
4.1.3. Preservation of the donor liver 
Organs deprived of circulating blood undergo damage. 
The degree of the damage depends mainly on the duration 
of the deprivation and on the temperature to which the 
organ is exposed during this period. Cooling of the donor 
liver alone cannot entirely prevent damage, and this has 
evoked an ongoing discussion as to the optimal 
composition of the preservation fluids to be used. 
4.1.3.1. The role of temperature 
Normothermic ischemia 
The study of the maximal tolerable normothermic 
ischemic time of the liver has been hampered by the fact 
that acute occlusion of the portal vein in many species 
is poorly 
effects on 
tolerated hemodynamically 
the bowe1. 8 Raffuci 
and 
and 
has profound 
Wangensteen 
circumvented these problems by a concomitant occlusion of 
the superior mesenteric artery during the occlusion of 
the arterial and portal venous supply to the liver.9 
Based on these experiments it was long believed that 20 
minutes was the maximal tolerable normothermic ischemic 
time of the liver. However, although congestion in the 
splanchnic venous system in these experiments was avoided 
by the occlusion of the superior mesenteric artery, 
normothermic ischemia of the bowel occurred 
concomitantly. In later experiments in dogs and pigs in 
which the portal venous system was decompressed during 
total hepatic inflow occlusion by means ·of a portocaval 
shunt or an external bypass, the maximal tolerable 
normothermic 
longer than 
hepatic ischemic time 
20 minutes,l0-12 
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appeared to be much 
Sixty minutes of 
normothermic hepatic ischemia in dogs and 120 minutes in 
pigs is considered to be safe.l3-15 In man, one hour of 
normothermic hepatic 
life. 16 Studies of 
ischemia seems to be compatible with 
this kind should, however, be 
evaluated critically, because the temperature of the 
liver drops considerably during vascular exclusion and 
even moderate cooling, i.e., 24 to 31°C, is 
a protective effect with respect to ischemic 
known to have 
darnage.l?,l8 
Moreover to assess the maximal tolerable normothermic 
hepatic ischemic time, the inflow occlusion has to be 
complete because an intact collateral circulation has 
shown to allow a longer tolerable period of hepatic 
artery and portal vein occlusion.l9 
The maximal tolerable period of normothermic ischemia 
alone is certainly insufficient for liver transplantation 
purposes in view of the lengthy duration of the 
procedure. Moreover, in clinical liver transplantation a 
large part of this period may be consumed even before the 
donor operation has been started, because hemodynamic 
instability is usually associated with the status of 
donorship. This situation underlines the importance of 
early optimal care of possible donor candidates. 3 During 
the donor hepatectomy the organ may sustain further 
damage due to manipulation. Various drugs have been used 
to counteract the reactive vasoconstriction during 
removal of donor organs,20 but the prevention by gentle 
manipulation is undoubtedly more important. In dogs, 
manipulation of the donor liver has been held to be at 
least partially responsible for the high incidence of 
liver outflow block during liver transplantation. 21 -24 
This phenomenon is ascribed to spasm of the small 
intraparenchymal hepatic veins, which have an 
extraordinarily well developed muscular coat, at least in 
dogs. 21 
The evaluation of the extent of normothermic ischemic 
damage in the donor liver seems to remain a major 
problem, as indicated by one of Starzl's statements: 
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"Even recently we transplanted hopelessly damaged organs 
taken from apparently good donors". 5 
Cold ischemia 
Hypothermia remains the cornerstone of organ 
preservation.20 The initial cooling of the donor liver 
has been performed by organ surface cooling, 22 total body 
surface cooling,21 total body 
cooling, 25 transportal vein 
extracorporeal circulation 
infusion cooling, 21 or 
combinations of these methods. The ideal preservation 
is still not temperature 
between 0 and l0°C. 20 
known, 
Since 
heart-beating donors in organ 
but is 
the 
believed to be 
acceptance of 
transplantation, the 
initial cooling has been achieved by transportal vein 
infusion of a solution at 4°C. Washing out of blood seems 
to be important, but the problem of immersional storage 
in a solution at 0°C versus continuous perfusional 
storage with a solution at 4°C has not been completely 
solved. 20 Immersional storage is most commonly used 
its simplicity and reasonably because of 
effectiveness 
hours. 4 ,5 
allowing safe preservation for up 
Ischemia during transplantation 
good 
to 12 
During insertion, rewarming of the graft occurs from 
the surrounding recipient tissues and can cause further 
damage. This can be partially prevented by protecting the 
graft from direct contact with the surrounding recipient 
tissues, by surface cooling of the graft, and by limiting 
the time taken by the insertion of the graft. 
4.1.3.2. The role of the composition of the preservation 
fluid 
Various preservation fluids are in use, which 
emphasizes that the ideal composition is not known. 
Originally Starzl et al.21 as well as Calne et al.26 used 
lactated Ringer's solution for preservation of donor 
livers but a delay in revascularization of these livers 
for more than a few hours was not compatible with life. 
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The main reason for this limitation was thought to be 
the composition of the preservation fluid and the 
experiments 
hypothesis. 27 
of Schalm 
Later on, 
tended 
however, 
to support this 
Schalrn et al. found in 
canine and porcine liver transplantation experiments no 
difference between the results obtained with 4 different 
types of preservation fluid, used for preservation times 
up to 6 hours, and concluded that the composition of the 
preservation fluid is of minor importance for a 
preservation period that long. 28 Using 3 different types 
of fluid in dogs for preservation of the liver for 9 
hours, Benichou et al. obtained consistent survival, 
irrespective as to the composition of the preservation 
fluid. After a preservation period of 18 hours consistent 
survival was not anymore achieved with any of the types 
of preservation fluid. However, a higher survival rate 
was obtained when, instead of lactated Ringer's solution, 
plasma or Collins' solution was used. Moreover Collins' 
solution appeared to be slightly superior than plasma in 
terms of survival and liver function. These authors 
concluded that the composition of the preservation fluid 
is not important for preservation times of 9 hours, but 
that the composition does matter with longer times.29 The 
study in dogs of Monden and Fortner support this 
conclusion. Consistent survival after a 24 hour period of 
preservation of the liver was only achieved when 
prostacyclin was added to the modified Sacks' solution. 
Unfortunately 
the addition 
these 
of 
authors did not test the 
prostacyclin to lactated 
effect of 
Ringer's 
solution, which was used for 24 hour preservation of the 
liver in the first group of dogs.30 
In clinical liver transplantation a safe preservation 
time of up to 12 hours is claimed by world's two leading 
teams. Starzl 
approaches the 
et al. use Collins' solution which 
composition of intracellular fluid. 5 In 
contrast Calne et al. use Hartmann's solution, followed 
by a plasma protein fraction solution with additions. 4 
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The latter solutions approach the composition of extra 
cellular fluid. In human kidney transplantation the use 
of Euro-Collins solution gives a safe preservation period 
for up to 50 hours.3 1 
The gradual prolongation over the 
preservation time of the liver, using 
types of preservation fluid, must be 
years of the safe 
basically the same 
related to a more 
careful avoidance of normothermic hepatic ischemia and to 
better cooling of the organ. The composition of the 
preservation fluid for longer preservation times than are 
actually used may, however, prove to be critical. 
4.2. The preoperative condition of the recipient 
Because of the nature of the diseases for which liver 
transplantation is required and due to the lack of 
effective methods for preoperative correction of the 
effects of a failing liver, most recipients have been 
poor surgical risks. Moreover a number of patients, e.g. 
with biliary atresia, may have undergone extensive 
abdominal surgery before liver transplantation. Even in 
the absence of prior abdominal surgery, severe bleeding 
peroperatively and infections postoperatively are major 
problems when the 
the course of the 
procedure 
disease, 
is 
and 
moribund 
carried out too late in 
patients with 
state should 
chronic 
not be liver failure in a 
transplanted. 4 , 32 - 34 In view of the moderate results of 
clinical liver transplantation, the procedure should not 
be carried out too early either. Close monitoring of the 
potential candidates seems to 
transplanting too early minimal.35 
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make the risk of 
4.3. Anastomotic problems 
The vascular anastomoses 
Vascular anastomotic problems, though serious when 
they occur, do not seem to have played a major role in 
the over-all fatality associated with clinical liver 
transplantation.S,36 The exact complication rate is not 
known, however, 
anastomosis have 
because the different types of 
not been monitored routinely.37 In 
contrast, a high incidence of hepatic artery thrombosis 
has been noted in canine liver transplantation.38 This 
complication can be largely prevented by the creation of 
an end-to-side arterial anastomosis with the use of a 
patch instead of an end-to-end anastornosis.38 Krom et al. 
use this method of arterial reconstruction in human liver 
transplantation,33 and a similar technique was employed 
in the experiments described in this thesis. 
The biliary anastomosis 
The 
called 
reconstruction of 
the Achilles' 
the biliary 
heel of 
tract has been 
clinical liver 
transplantation, complications accounting for more than 
one-third of the fatalities.5,39-44 A major problem has 
been anastomotic leakage or obstruction. A multifactorial 
etiology for this problem is probable. 
As early as 1960, Starzl et al. reported for canine 
liver transplantation that the gallbladder must be opened 
to prevent autolysis. 21 Almost 20 years later, Syrakos et 
al. found that in the rabbit the presence of bile in the 
gallbladder during cold preservation leads to extensive 
damage of the wall and that 
can prevent this damage.45 
found a relationship 
prior evacuation of the bile 
In the pig, McMaster et al. 
between cold ischemia and 
biliary-tree 
was left in 
preservation. 
damage, but in these experiments the bile 
situ during the 24-hour period of cold 
However, no damage was seen after one hour 
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of normothermic preservation in the presence of bile.46 
Northover and Terblanche drew attention to the poor 
blood supply to the supra-duodenal portion of the common 
bile duct in man compared with the 
and baboon. Furthermore, the 
situation in the pig 
duodenal side 
greater share in this blood supply than the liver 
takes a 
side.47 
Long donor common bile ducts are therefore undesirable, 
and shortening has reduced the incidence of anastomotic 
leakage9 4 
Another problem concerning the biliary tract in liver 
transplantation is the development of biliary sludge or 
casts. When this complication was first reported, all of 
the patients had previously developed a biliary leak.48 
This suggests that infection and anastomotic scarring 
with subsequent stenosis are mainly responsible for this 
phenomenon. In fact, all cast cultures were found to be 
positive for Escherichia coli. 49 In Starzl's experience a 
mechanical etiology almost always plays a role. 41 An 
altered lithogenicity has 
co-responsible. 48 In 1979, in a 
been postulated 
series of 34 
to be 
patients, 
McMaster et al. found a 60% incidence of early sludge 
intraluminal obstruction and formation leading to 
cholangitis. 49 Because this complication was much less 
common in Starzl 1 s series, the question arises whether 
the gallbladder conduit technique, developed and used by 
Calne 1 s team, 40 is responsible for this complication. 
For the prevention of cholangitis, the advantage of 
retaining Oddi's sphincter has been clearly demonstrated 
in animals,50,5l and the choledocho-choledochostomy 
to be the anastomosis a T-tube is considered 
choice. 4 ,S,33,51 Although 
over 
of 
Calne too retains Oddi's 
sphincter, he interposes the gallbladder as a conduit.40 
Unfortunately, a 
biliary anastomosis 
example in children 
sphincter-retaining technique for 
is sometimes not feasible, for 
with biliary atresia.s Under these 
conditions Starzl et al. prefer a choledocho-jejunostomy 
at present, 5 whereas Calne and Williams use an 
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anastomosis between the gallbladder conduit and the 
jejunum. 4 A cholecysto-intestinal anastomosis should be 
avoided in view of the high incidence of cholangitis and 
cystic duct obstruction. 5 , 39 , 42 , 49,51,52 Moreover the 
gallbladder should always be removed if a 
choledocho-intestinal 
the high incidence 
anastomosis is performed because of 
of cholecystitis in case of 
nonremova1. 51 
4.4. Rejection 
The first clinical kidney-transplantation trials were 
performed in patients whose state had not been altered by 
therapy, because immunosuppressive drugs such as 
prednisolone and azathioprine were not yet available. As 
a result, the natural course of rejection of renal 
transplants in man is well known. Analogous information 
about liver-transplant rejection in man will never be 
obtained, because all human recipients receive 
immunosuppressive therapy~ Therefore, the only recourse 
is to extrapolate data on rejection phenomena in 
non-immunosuppressed animal recipients to man.53 
In unmodified unrelated canine recipients the 
survival time usually does not exceed 10 days. 54 For 
unmodified unrelated baboons Mybergh et al. reported a 
14-day survival of 25%, and only 
much as 36 days.ss Although 
one baboon lived for as 
various regimens 
immunosuppressive therapy mitigated rejection, 
of 
the 
long-term survival rate in dogs and baboons remained low. 
Moreover, in _about one -third of the canine recipients, 
the course of rejection was not significantly changed by 
the use of immunosuppressive drugs.56 In pigs a different 
natural course of rejection was first observed by Garnier 
et al. Changes in liver biochemistry were found to be 
less pronounced, and a few pigs lived for more than 25 
days&57,58 These findings were confirmed by Peacock, 
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Terblanche and Calne,26,59-6 2 but consistent long-term 
survival in unmodified pigs has not been achieved. 50 
Clinical liver transplantation was given a trial 
because of the relatively great success of clinical 
kidney transplantation. 53 These trials showed clearly 
that acute rejection was less of a problem in liver than 
in kidney 
blood-group 
transplantation, even under 
or histocompatibility-matching 
violation of 
rules.39,63 
Moreover, rejection appeared to account for less than 10% 
of the deaths.6 4 , 65 Thus, donor-recipient selection based 
on tissue-typing appeared to be much less important here 
than in clinical kidney transplantation, although a 
prospective study of the effect of typing has never been 
possible because of the urgent demand for and shortage of 
donor livers 66 and the small acceptor pool in the absence 
of an artificial liver. In view of above findings and the 
fact that significant extrahepatic infections were found 
in almost all deceased recipients, systematic 
over-immunosuppression was considered to be at least 
partially responsible for the high fatality rate.64,65 
Some authors have compared the course of rejection in man 
and the pig,4,65 but this comparison is not valid because 
all human recipients have been given immunosuppressive 
therapy whereas most of the porcine recipients were not. 
Starzl et al. warned against lightening of the 
immunosuppressive regimens in clinical liver 
transplantation, and pointed out that some of the 
structural abnormalities in the hepatic grafts,thought to 
be nonspecific, could be subtle manifestations of hepatic 
rejection or recovery from rejection phenornena.64 More 
recently, Starzl et al. stated that the tendency to 
ascribe most of the high fatality rate to non-rejection 
factors is probably not completely correct, and they 
thought that the next major improvement of survival would 
follow advances in the field of immunosuppression.s This 
prediction seems to have been fulfilled by the 
introduction of cyclosporin A. 67 - 70 However, the improved 
54 
techniques and the better recipient selection undoubtedly 
have to be taken into account for the better results 
achieved since 1980 (Chapter 5). 
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CHAPTER 5, RESULTS OF ORTHOTOPIC LIVER TRANSPLANTATION IN 
CHILDREN 
Of the two leading teams in the world in the field of 
clinical liver transplantation, only one has accumulated 
considerable experience with pediatric liver 
transplantation. In the past, Calne and his team were 
reluctant to transplant children because of the uncertain 
long-term prognosis, the frequent and often painful pre-
and postoperative 
drugs. 1 The recent 
investigations, and the side effects of 
improvement of the prognosis and the 
availability of cyclosporin A for use as an 
immunosuppressive drug have changed this attitude, but 
the shortage of appropriately sized donor livers has 
hampered this team's work on the development of pediatric 
liver transplantation. 2 
In contrast, between 1963 and May of 1982 Starzl and 
his team transplanted 112 patients aged 18 years or 
younger, which amounts to about 50% of all 
transplanted by this team. Sixty- three of 
patients had biliary atresia, 21 an inborn 
patients 
the 112 
error of 
metabolism, 15 chronic aggressive hepatitis, and the 
remaining patients a variety of conditions, as underlying 
disorders leading to end-stage hepatic disease. Only 
three 
hepatic 
pediatric patients received a transplant for 
malignancy. Of the 86 pediatric patients 
transplanted before 1980, 38% were alive at one year and 
21% are still alive with a follow-up duration ranging 
from 2.5 to 12.5 years. Of the 26 pediatric patients 
transplanted since 1980, 70% are still alive with a 
follow-up period ranging from one to 21 months. The 
one-year survival rate has therefore been roughly 
63 
doubled. Starzl attributes this improvement to the use of 
cyclosporin A and a reduced steroid dosage. 3 The better 
recipient selection and the improved techniques for the 
biliary anastomosis have, however, certainly contributed 
to this improvement.2 
Before 1980 the results in the pediatric age group 
were distinctly better than those obtained in adults, but 
this does not hold when the group of children with 
biliary atresia is 
Since 1980, the 
compared with the group of adults. 
discrepancy between the results in 
pediatric and adult recipients has disappeared, as has 
the discrepancy between those in pediatric recipients 
with and without biliary atresia.3 The use of 
microsurgical techniques in recipients with biliary 
atresia, who are usually smaller than other pediatric 
liver-transplantation candidates,4 together with the 
awareness that 
these patientss 
for the biliary 
associated anomalies may be present in 
and the availability of better techniques 
anastomosis in the absence of a recipient 
common bile duct, seem to explain the disappearance of 
the discrepancy 
recipients with and 
between the results in pediatric 
without biliary atresia. The present 
5-year survival rate is not known, however. 
In the Groningen University Hospital (The Netherlands) 
two children have been transplanted 
children was 11 years old and 
cirrhosis, the other was 4 years 
so far. One of these 
had cryptogenetic 
old and had biliary 
atresia. Both are doing well with follow-up durations of 
one year and three months, respectively.6 
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CHAPTER 6. THE EXPERIMENTAL DESIGN 
6.1. The experimental animal: the beagle 
The ready availability of inbred strains of rats at 
relatively low cost has favored the use of this species 
in 
led 
transplantation 
to consistent 
work. The use of isogeneic grafts has 
long-term survival after liver 
transplantation, which argues for the soundness of the 
techniques used. The same techniques have been used in an 
allogeneic combination to assess the effect of various 
immunosuppressive regimens.1,2 
Although the validity of this work is beyond doubt, 
the anesthesiological and surgical techniques used differ 
considerably from those applied in clinical liver 
transplantation, and a 
mimic the clinical 
larger animal is 
situation. However, 
necessary to 
consistent 
long-term 
or monkey 
survival has not been achieved in the dog, 
(Section 4.4). For the evaluation of 
pig, 
the 
techniques used in these species, long-term survival is 
essential and the role of immunological factors in the 
outcome must be eliminated as far as possible. Selection 
of donor and recipient among littermates matched for the 
major histocompatibility complex can bring this goal into 
sight, but the cost will unfortunately be high. 
For the present study the beagle was chosen as 
experimental animal because of the availability of a 
large outbred colony (Centraal Proefdieren Bedrijf TNO, 
Zeist, The Netherlands), excellent tissue-typing 
facilities, and the know-how in the handling and care of 
the beagle in various kinds of organ transplantation 
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experiments 
University 
in 
in 
the Surgery 
Rotterdam (The 
Laboratory of Erasmus 
Netherlands). 3 - 5 In 
addition, much is known about the anatomy, physiology, 
and pathology of the beagle,6 and dogs have been used for 
many years in experimental liver transplantation. 7 -1 4 
6.2. Mitigation of rejection 
Although in beagles from the indicated colony 
rejection after various kinds of organ transplantation 
can be mitigated considerably by donor-recipient 
selection of littermates which are matched for the major 
histocompatibility complex, rejection does occur. 4 The 
survival period after orthotopic liver transplantation in 
this donor-recipient combination appeared to be much 
longer than those reported for other kinds of organ 
transplantation, but the only series published was too 
small to permit definite conclusions.l4 In contrast, 
Chandler et al4 were, unable to achieve long-term 
survival in tissue-typed identical beagles from a 
selectively bred colony.12 However, long-term survival is 
essential for the evaluation of surgical transplantation 
models. On these grounds, the experiments were done in 
littermate pairs matched for the major histocompatibility 
complex, and prednisone and azathioprine were given to 
the recipients. 
6.3. The design of a control model 
To obtain an impression of the impact of the surgical 
trauma alone on the outcome, i.e., in the absolute 
absence of rejection, 
resembling 
hepatic vascular exclusion 
experiments autotransplantation, were 
performed as control experiments. The effect of the 
immunosuppressive drugs on the outcome of these 
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experiments was assessed by giving half of the control 
dogs the same immunosuppressive treatment as that given 
to the transplanted dogs. 
6.4. The orthotopic nonauxiliary mode of partial liver 
transplantation 
The shortage of appropriately sized donor livers for 
pediatric liver transplantation would be increased by a 
nonremoval of the native liver, because the space 
occupied by the latter would not become available. For 
auxiliary liver transplantation in children, even 
age-matched donor livers would be too large and livers 
from younger donors would be required. Apart from the 
problem of size, removal of the native liver may be 
indicated, e.g. in children with biliary atresia (Section 
2.2). Furthermore, one should know what happens to a 
partial graft placed in an orthotopic nonauxiliary 
position, before one embarks on heterotopic auxiliary 
transplantation of such a partial graft and is confronted 
with the difficult problem of graft atrophy. Lastly, in 
the absence of the native liver, total liver function is 
graft dependent, which greatly simplifies evaluation of 
the functioning of the graft. 
For all of these reasons, the orthotopic nonauxiliary 
mode of partial liver transplantation was chosen for the 
experimental study. 
6.5. The age of the animals at operation and the size of 
the partial grafts 
The ideal experimental set up would have been the 
transplantation of part of an adult canine liver into a 
puppy, the size of the graft equaling the size of the 
puppy's liver, but this would have made it impossible to 
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use littermate dogs. Moreover, it would have been 
extremely difficult to obtain an adequate number of 
comparable donor-recipient pairs. For these reasons, only 
adult beagles were used. The size of the graft was 
arbitrarily chosen to represent 60% of the donor liver. 
In the control experiments, 60% of the native liver was 
left in situ. 
6.6. The duration of liver ischemia 
To mimic the clinical situation, in which longer 
periods of ischemia of the donor liver are required, 
donor and recipient dogs were operated on sequentially. 
According to this policy, the total ischemic time of the 
graft was about 5 hours, but in the control experiments 
the same total ischemic time of the liver could not be 
achieved without a concomitant and equal prolongation of 
the anhepatic phase. As a debatable compromise, the 
duration of the anhepatic phase in these dogs was set at 
about 20 minutes longer than in the transplanted dogs. 
6.7. The duration of the period under study 
Dogs surviving for 169 days after surgery were killed. 
A longer survival has rarely been reported for canine 
orthotopic liver transplantation.7-14 This period was 
thought to be sufficiently long for the evaluation of the 
techniques used. 
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Summary 
An experimental study was carried out in dogs to 
investigate the feasibility of using only a portion of a 
donor liver in orthotopic nonauxiliary transplantation. 
After being totally hepatectomized, 20 immunosuppressed 
adult beagles 
originating from 
received a 60% 
tissue-typed 
donor liver graft, 
identical littermatese 
Preservation time was 5 hr. In control experiments, 10 
beagles, only half of them immunosuppressed, underwent an 
operation involving complete liver mobilization, vascular 
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exclusion, cooling of the liver in situ, a 40% partial 
hepatectomy, revascularization of the liver remnant, and 
biliary anastomosis. The surgical procedure, including 
the method of cooling and preservation, is described in 
detail. The survival rate amounted to 90% for the control 
group and 50% for the transplanted group, while all 
surviving dogs were sacrificed 24 wk postoperatively. At 
sacrifice, the liver weight amounted to the weight of the 
total native liver at operation. Body-weight profiles 
reflect good general condition of the surviving dogs. No 
major differences were noted between the immunosuppressed 
and the nonimmunosuppressed control dogs. No 
complications were related to the fact that only a 
partial liver was grafted or left in situ. 
Introduction 
Shortage of donor livers of an appropriate size is a 
major problem in pediatric liver transplantation. 1 ' 2 
Juvenile donor livers are not readily obtainable and may 
also be grafted into adult recipients,3 rendering the 
shortage of organs for pediatric transplantation even 
more acute. Adult donor livers, although more readily 
obtainable, are generally unacceptably large for 
pediatric recipients, even for orthotopic, nonauxiliary 
grafting. 4 ' 5 This problem would be solved if a partial 
donor liver would suffice. 
We investigated the feasibility of using only part of 
a donor liver instead of the whole liver in orthotopic 
nonauxiliary transplantation. We report the development 
of a successful canine model, including a control model 
to determine the effect of factors other than rejection. 
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Materials and methods 
Our laboratory animals consisted of male adult beagles 
from an outbred colony. In a randomized sequence we 
carried out 20 transplantations and 10 control 
experiments. 
(169 days) 
The surviving dogs were sacrificed 24 wk 
after surgery. Age at operation and body 
weight of donor,recipient, and control dogs are given in 
Table 1. The donor-recipient pairs came from the same 
litter and identicalness was substantiated by serologic 
and mixed lymphocyte culture typing.6,7 The heavier one 
of the pair always became donor. Standardized 
immunosuppression (Table 2) was added to prolong the 
survival period. Half of the control dogs underwent the 
same immunosuppressive treatment. No blood transfusions 
Table 1. Age and body weight at operation. 
control dogs 
donor dogs 
recipient dogs 
Table 2. Immunosuppression. 
postoperative 
days 
0-99 
100 - 107 
108-127 
128- 149 
> 150 
age: 
mean in 
days!lSD 
484.9 + 81. TO 
479.55+78.81 
azathioprine* 
mg/kg per day 
0.75 
0.50 
0.25 
0 
*Kindly supplied by the Well come Foundation 
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body weight: 
mean in 
kg! 1 SD 
13.5 ± 1.6 
14.1+1.6 
12.8 ± 1.3 
prednisolone 
mg/kg per day 
2 
1.5 
1.0 
0.5 
0 
were given preoperatively. Parenteral lincomycin and 
kanamycin were administered on the day of surgery and the 
following day. 
Anesthesia was initiated with fentanyl, 
dehydrobenzperidol, and atropine. Following induction 
with fentanyl and muscle relaxation with pancuronium, 
endotracheal intubation was carried out and artificial 
ventilation was started. Anesthesia was maintained with 
N2o, o 2 , and enflurane. Intravenous fluids consisted of 
electrolyte solutions, fresh blood, and fresh plasma. At 
the end of the operation, anesthesia was maintained until 
rewarming up to 36°C had been accomplished. 
A standardized protocol was followed. The right 
femoral artery was cannulated for pressure monitoring in 
all dogs and for bleeding purposes in controls. In 
recipient and control dogs, the right external jugular 
vein was used for central venous pressure monitoring and 
for blood sampling, while the right femoral vein and left 
external jugular vein were used for bypass purposes. 
Abdominal access was gained by an extended right 
subcostal laparotomy in all dogs. Euro-Collins solution 
at 4°C was used for cooling and preservation of the 
liver. The composition is given in Table 3. 
The donor dog is operated on first. Manipulation of 
the liver proper is carefully avoided until the liver has 
been cOoled in situ. Dissection of the hepatoduodenal 
ligament close to the duodenum is initiated by ligation 
and division of the right gastric vessels. The common 
bile duct is ligated and transected. The gastroduodenal 
artery is ligated close to the duodenum and cannulated 
retrogradely in the direction of the liver with a soft 
transparent catheter, which is sealed until the cold 
arterial infusion can begin. The portal vein is then 
freed. After 5 min of bleeding via the femoral artery, 
the gastroduodenal, splenic, and superior mesenteric 
veins are ligated and a short, large-caliber cannula is 
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Table 3. CamP9sition of Euro-Collins solution. 
components 
J. KH 2P04 
2. K2HP04 
3. K Cl 
4. NaHC03 
5. Glucose 
Osmolality: oOOut 355 mmol/1 
pH at 20°C: 7.33 
pHot 4°C:7.20 
g/liter 
2.05 
7.4 
1.12 
0.84 
35 
K 
No 
mmol/1 
115 
10 
15 
10 
85 
15 
inserted into the portal vein. The cold infusion is 
initiated under a hydrostatic pressure of 75 em of water. 
Through a hole in the diaphragm, the infracardiac 
caval vein is occluded. At the level of the renal veins, 
the intrahepatic caval vein is also occluded, and an 
immediately proximal caval venotomy enables drainage of 
the perfusate. To prevent autolysis, the biliary system 
is flushed manually with 0.9% saline at 4°C through the 
gallbladder, until the common bile-duct effluent becomes 
clear. Next,the gallbladder is opened wide. Further 
dissection is delayed until 2 liters of cold infusion 
have passed through the portal vein, cooling the liver 
down to 12°C. The common hepatic artery is then mobilized 
and transected, including a patch of the celiac trunk. 
The liver proper is now mobilized by dividing the 
various ligaments, first on the left and then on the 
right. The retrohepatic caval vein, which remains 
attached to the liver, is freed from the renal veins up 
to the diaphragm. The intrahepatic caval vein is 
transected distal to the ligated right adrenal vein. The 
suprahepatic caval vein is mobilized, including part of 
the cuff of the tendinous diaphragm, and transected 1 ern 
above the diaphragm. Upon removal the liver is packed in 
two sterile plastic bags, the inner one containing cold 
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preservation fluid and the outer one melting ice. Storage 
takes place in the refrigerator at 4°C. 
The recipient dog is prepared to accept the graft and 
then bench surgery is carried out on the donor liver. At 
this stage the liver has cooled down to about 4°C. It is 
put into a sterile basin containing melting ice, and 
infused with 500 ml of cold normal saline solution to 
remove the potassium-rich Euro-Collins solution. An over 
and over SxO ProleneR suture is applied to the posterior 
diaphragmatic cuff to make certain that all phrenic vein 
inlets are closed. Next, 40% of the liver is removed, 
i.e., the left liver lobes. This is achieved by careful 
hilar dissection as described by Sigel.s All individual 
structures are ligated separately and transected as 
peripherally as possible. With the back of a surgical 
blade the parenchymal bridge is divided, and all larger 
structures are divided between ligatures until the left 
hepatic vein is reached. The hepatic parenchyma is 
stripped off this vein, which is ligated with a heavy 
silk ligature. After removal of the gallbladder, a soft 
splint with one terminal and one lateral opening is 
passed through the common bile duct (Fig.l). 
In the recipient dogs, the portal vein is extensively 
mobilized with preservation of the gastroduodenal vein. 
Subsequently the celiac trunk is freed. Mobilization of 
the liver lobes and retrohepatic caval vein proceeds as 
in donor dogs, but the right adrenal vein is left intact. 
Hepatic arteries and bile ducts are ligated and divided 
close to the liver. The largest duct, which drains the 
central lobes and the gallbladder, is marked for 
subsequent anastomosis. 
Decompression of the distal venous systems during the 
slightly modified anhepatic 
Cooperman 
nasogastric 
phase is 
technique. 9 
achieved 
Three 
tubes, cut to 
by a 
siliconized, gauge-18 
appropriate lengths, are 
assembled in an inverted Y fashion, and the system is 
filled with 0.9% saline solution. The top end of the 
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SPLINT 
Fig. 1. Bench surgery on the donor liver. 
The left medial and lateral lobes ore removed as well as the gallbladder. A splint is inserted 
in the common bile duct via the cystic duct. 
Fig. 2. The femoro-porto-jugular bypass during the onhepatic phose. 
SHCV =suprahepatic caval vein; IHCV = infrahepatic caval vein; PV =portal vein; LEJV = 
left external jugular vein; RFV =right femoral vein; CVP =central venous pressure; ABP"" 
arterial blood pressure 
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inverted Y is inserted into the left jugular vein, and 
the end of one of the arms into the right femoral vein. 
The portal vein is transected as close to the liver as 
possible, and the end of the other arm of the inverted Y 
is inserted into the proximal portal vein, distal to the 
entrance of the gastroduodenal vein.10 The portal bypass 
clamp is then removed. The intrahepatic caval vein is 
clamped just above the entrance of the renal veins and at 
the liver level, after which it is transected immediately 
distal to the proximal clamp. The liver is now pulled 
downwards and the suprahepatic caval vein is occluded 
with a large Satinsky clamp involving a portion of the 
diaphragm (Fig. 2). The remaining bypass clamps are 
removed. 
The liver is stripped from the caval vein until the 
cloaca of the hepatic veins is encountered, at which 
level the caval vein is once more transected, completing 
the recipient hepatectomy. Cold moist gauze is placed in 
the hepatic bed to receive the transplant. The 
suprahepatic caval anastomosis is performed in an 
end-to-end manner, using continuous 5 x 0 Prolene. Next, 
the portal vein is anastomosed. With the portal limb of 
the bypass in situ, the posterior layer is sutured with 
continuous 6 x 0 Prolene. Under total portal vein 
occlusion, after removal of the portal bypass, the 
anterior layer is closed rapidly to 
revascularization.lO Approximately 
be followed by portal 
200 ml blood is 
drained off through the intrahepatic caval vein, to allow 
discharge of waste products and air. The donor 
intrahepatic caval vein is then clamped and the clamp on 
the suprahepatic caval vein is released. Once continuity 
of the intrahepatic caval vein has been achieved, the 
remaining parts of the bypass are removed. Attention is 
now focused on the arterial reconstruction (Fig. 3). 
After amputation of the recipient common hepatic 
artery, including a slice of the recipient celiac trunk, 
an end-to-side anastomosis is performed with continuous 
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Fig. 3. The arterial anastomosis. 
DGDA =donor gastroduodenal artery; DPHA =donor proper hepatic arteries; DCHA =donor 
common hepatic artery; RGDA =recipient gastroduodenal artery; RPHA =recipient proper 
hepatic arteries; RCHA =recipient common hepatic artery; RLGA =recipient left gastric 
artery; RSA =recipient splenic artery; RCT =recipient celiac trunk; RAe= recipient aorta. 
DONOR RECIPIENT 
...._, ... 
( 
Fig, 4. The biliary anastomosis. 
GB =gallbladder 
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6 x 0 Prolene. The anastomosis is flushed via the 
catheter in the gastroduodenal artery and patency is 
confirmed, after which the catheter is removed. Lastly, 
biliary drainage is achieved by a splinted choledocho-
choledochostomy, using interrupted 6 x 0 Prolene sutures 
(Fig. 4). Upon hemostasis the abdomen is closed in one 
layer, using interrupted silk. The end of the biliary 
splint is sealed with a plastic cap and buried in a 
subcutaneous position distal to the 
subsequent puncture cholangiography. 
Control experiments 
incision for 
For the control dogs our surgical procedure was a 
derivative of Dent et al.'s experimental autografts in 
pigs. 11 The hepatoduodenal ligament is transected as in 
the donor dogs, including the common bile duct but 
excluding the portal vein and hepatic artery which have 
been freed. The gastroduodenal artery is transected too 
and cannulated retrogradely, leaving the vein intact. 
Mobilization of the liver proceeds as in the recipient 
dogs, except that the left phrenic vein is doubly ligated 
and severed. This permits suprahepatic caval vein 
occlusion without compromising the left hepatic vein 
outlet. Bypassing is achieved as in the recipient dogs. 
The portal branch is introduced 
vein through a longitudinal 
into the proximal portal 
venotomy distal to the 
entrance of the gastroduodenal vein and secured without 
compromising the latter vein. Through the same venotomy 
the distal portal vein is connected to the cold infusion 
system (Fig. 5). Clamping of the hepatic artery completes 
the interruption of the afferent blood supply. 
The caval vein is clamped above and below the liver as 
in the recipient dogs, and an intrahepatic venotomy 
permits perfusate drainage. The cold arterial and portal 
infusion is initiated and the biliary tree is flushed as 
in the donor dogs. After 2 liters of cold infusion, the 
left liver lobes are removed. A cholecystectomy is 
performed and a splint inserted through the proximal 
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L.P,\1, 
PORTAL 
.......... 
G.D.\1. 
\_ 
PORTAL LIMII 
""""" 
S.\1. 
-·,~ 
Fig. 5. Portal infusion and bypass in control dogs. 
PV""' portal vein; RPV-:= right portal vein; LPV = left portal vein; GDV =gastroduodenal vein; 
SV =splenic vein; SMV =superior mesenteric vein 
common bile duct. After 1 hr of vascular exclusion, the 
portal branch of the bypass is removed and the portal 
venotomy is closed transversely with continuous 6-0 
Prolene sutures. The portal vein and hepatic artery 
clamps are removed and the liver is revascularized. 
Approximately 200 ml blood is drained off, the 
intrahepatic caval vein is occluded and the suprahepatic 
caval vein reopened. The caval venotomy is closed with 
continuous 5 x 0 Prolene sutures, 
and remaining bypass are removed. 
upon which the clamps 
Finally, a splinted 
choledocho-choledochostomy 
recipient dogs. 
is performed as in the 
Postoperative follow-up 
To check the various vascular anastomoses, pervenous 
angiography was carried out on the 4th and 11th post-
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operative day and also on indication. The angiographic 
technique and results have been published. 12 For the 
biliary anastomosis, percutaneous catheter cholangio-
graphy was performed on the 32nd postoperative day, at 
sacrifice, and on indication. 
Results 
None of the recipient or control dogs succumbed during 
surgery. The mean duration of the entire procedure, with 
specification of the individual phases, is given in Table 
4. A 5-hr duration of hepatic ischemia could not be 
achieved in the 
prolongation of the 
Table 4. Peroperative results. 
duration 
total operation 
donor 
recipient or contra I 
bench surgery 
anhepati c phase 
total liver ischemia 
control group without a 
anhepatic phase. 
concomitant 
transplantation experiments 
mean in minutes+ 1 SD 
116.20+11.40 
334.05 +21.96 
32.25+ 7.46 
53.05 + 4.47 
308.05 + 19.62 
control experiments 
mean in minutes+ 1 SO 
287.60+21.82 
70.40 + 5.73 
70.40 + 5.73 
Ten of the 20 recipients and 9 of the 10 control dogs 
survived for the duration of the experiment and were 
sacrificed 169 
one control 
days 
dog 
postoperatively. 
died within 2 
Two recipients and 
days; 4 recipients 
succumbed during the second week, 3 during the second 
month and one died more than 4 months postoperatively. 
The postoperative survival period, cause of death, and 
gross appearance of the liver at autopsy are given in 
Table 5. 
Three recipient dogs and one control dog developed 
overt morbidity. One of these 3 recipients as well as the 
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Table 5. Postoperative survival period, cause of death, and liver appearance at autopsy in dogs 
dying before the l69th day. 
survival period cause of death liver appearance at autopsy 
Transplantation group. 
1. 3 he 
2. 24 hr 
3. 8 days 
4. 9 days 
5. 1 l days 
6. 14 days 
7. 32 days 
8. 37 days 
9. 39 days 
10. 127 doys 
air embolism 
hypoglycemia 
peritonitis (leak biliary anastomosis) 
peritonitis (leak dislodged biliary 
splint) 
hemorrhage (bleeding duodenal ulcer) 
peritonitis (hepoti c artery thrombosis) 
peritonitis (leak after withdrawal 
biliary splint) 
sacrifice (poor general condition) 
sacrifice (liver failure) 
peritonitis (peripheral bi I i cry I eok after 
percutaneous biopsy) 
unremarkable 
reddish-blue, hard 
thickening of Glisson's capsule, 
parenchyma unremarkable 
thickening of Glisson's capsule, 
parenchyma unremarkable 
unremarkable 
total liver necrosis 
thickening of Glisson's capsule, 
parenchyma unremarkable 
central lobes: necrosis, right lobes: 
unremarkable 
generalized atrophy 
thickening of Glisson's capsule, 
parenchyma unremarkable 
Control group. 
1. 16 hr sacrifice (neurologic sequel!ae after 
anesthetic occident) 
unremarkable 
Table 6. Clinical morbidity and autopsy findings in recipient dogs surviving for 169 days. 
clinical morbidity ascites transplant appearance 
1. persistent jaundice 100 ml firm, micronodular 
2. slightly increased consistency 
3. unremarkable 
4. edematous, yellowish speckled 
5. wound infection right lobes: unremarkable, central lobes: few pseudocysts 
6. slightly increased consistency 
7. unremarkable 
8. leak biliary anastomosis 50 ml subphrenic abscess 
9. unremarkable 
10. unremarkable 
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control dog had to be reoperated 
biliary anastomosis, bringing the 
anastomotic leakage up to 10% for 
for leakage of the 
total incidence of 
both groups. The 
control dog recovered without sequellae, but the 
recipient developed a subphrenic abscess. Another 
recipient became permanently jaundiced after removal of 
the biliary splint on the 32nd postoperative day. At 
sacrifice no obstruction could be identified, but the 
liver had a firm micronodular aspect and there was also 
some ascites. The remaining recipient developed a severe 
wound infection, which healed spontaneously. Several 
weeks later the dog became febrile and vomited for a few 
days, but this subsided. At sacrifice, however, a few 
small pseudocysts were noted in the central lobes of the 
liver. Grossly, most of the other grafts looked healthy 
(Table 6). In the control dogs, a slight increase in 
liver density was sometimes noted, but never ascites. 
The recipients showed a mean gain of 0.36 kg in body 
weight, and in the control dogs this amounted to 1.58 kg 
(Table 7). Although the weight gain was statistically 
significant in the control group, the difference in 
weight gain between the two groups was not significant. 
Table 7, Changes in body weight in dogs surviving for 169 days. 
mean in kg 
+ 1 SD 
recipient dogs 
n = 10 
+ 0.36 
+ 1.95 
control dogs 
n=9 
+ 1.58 
:!: 1.28 
The weight of the liver at sacrifice was compared with 
the weight of the native liver at operation (Table 8). In 
control dogs the weight of the total native liver was 
estimated from the weight of the severed left lobes, 
according to the following formula: 
weight of the left lobes x 100 
total native fiver weight 
40.68 
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These estimates can be considered reasonably accurate, 
since the weight of the left lobes of the 20 donor and 20 
native recipient livers amounted to 40.68% (SD 2.72) of 
the individual total liver weight. At autopsy, the weight 
of the transplanted liver amounted to 102% of the native 
recipient liver. In the 
autopsy amounted to 105% 
control dogs the liver weight at 
of the peroperative total liver 
weight. The difference between the two groups is not 
significant. The same holds for the comparison of 
immunosuppressed and nonimmunosuppressed control dogs. 
Table 8. Liver weight at sacrifice on day 169 as a percentage of the native liver weight. 
recipient dogs control dogs 
n"" 10 n=9 
% % 
95.69 185.18 
89.88 98.29 
101.65 134.49 
110.59 103.46 
116.51 75.59 
96.03 112.37 } 85.58 65.15 127.24 90.81 no immunosuppression 
97.61 86.95 
105.09 
mean 102.58 105.81 
SD 12.64 36,01 
Discussion 
Consistent long-term survival is required before 
accrediting a surgical model in organ transplantation. In 
our series 50% of the recipient and 90% of the control 
dogs survived for the duration of the experiment, 
amounting to 169 days. While the 
can be attributed largely to 
89 
peroperative survival 
the quality of the 
anesthesiologic and surgical techniques, long-term 
survival 
procedure, 
demonstrates the soundness of the whole 
particularly the efficacy of the control of 
rejection. The effectiveness of the cooling and 
preservation techniques is demonstrated by the fact that 
only one animal, the first recipient dog, died as a 
result of early liver failure. This was due to an 
inadvertently high temperature of the refrigerator 
containing the preservation fluids and donor liver. 
Cooling of the donor liver in situ prior to mobilization 
has been generally abandoned in clinical practice since 
the acceptance of heart-beating donors. In our pilot 
experiments, however, we found that extensive 
mobilization prior to 
carried out, always 
cooling, 
resulted 
no matter how carefully 
in superficial liver 
bruises. 
become 
In addition, some areas would take longer to 
bloodless during cold infusion, and post-
transplantation revascularization was delayed in these 
areas. Perhaps this might explain 
hopelessly damaged livers having been 
apparently good donors.l3 With the 
premobilization cooling of the liver 
experiments, bruises were avoided 
Starzl's report of 
transplanted from 
technique for early 
developed in our 
and a much more 
homogeneous cooling and revascularization process was 
obtained. The decompression of the occluded venous 
systems achieved during the anhepatic phase was 
sufficient to prevent uncontrollable hemodynamic changes, 
although urine output almost ceased during the bypassing 
period and most of the dogs had a loose stool mixed with 
some blood upon awakening. 
The systematic checking 
pervenous angiography,l2 
of all vascular anastomoses by 
and of all biliary anastomoses 
by percutaneous catheter cholangiography, permitted exact 
assessment of the anastomotic complication rate in our 
series. Although arterial thrombosis is a common and 
fatal complication in canine liver transplantation,l4 it 
occurred only once in our series. The diagnosis was the 
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result of routine pervenous angiography in the absence of 
any clinical manifestation. Unfortunately, reclotting 
occurred after initially successful thrombectomy. No 
other vascular anastomotic complications occurred in the 
entire series. 
As in clinical liver transplantation, the biliary 
anastomosis represented the Achilles' heel in our 
experimental series. 13 ,15-l? Anastomotic leakage occurred 
with a 10% incidence in both groups. Of the 3 dogs 2 were 
reoperated and both survived, which underscores the 
importance of early diagnosis and reintervention. Severe 
biliary splint complications occurred in 3 transplanted 
dogs, with fatal results in 2 of them. A more careful 
insertion of the splint, which was left in situ for the 
entire survival period, prevented complications in the 
second half of the series. 
The notion of transplanting a portion of a donor liver 
is not new. Experimental heterotopic 
homotransplantation of canine liver lobes 
as outside the abdominal cavity has been 
auto-, and 
inside as well 
reported. 18 - 2 l 
Heterotopic partial liver homotransplantations have even 
been carried out in patients. 22 r 23 In animals auxiliary 
homotransplantation of a portion of a donor liver, with 
partial removal of the native 1 i ver, has also been 
reported. 24,25 None of these models proved entirely 
successful. Orthotopic nonauxiliary homotransplantation 
of a partial liver has not been reported before. In our 
model the animal survival equals the graft survival, and 
the hepatic function is entirely dependent on the graft. 
Our model also bypasses the difficult and ongoing 
discussion on the etiology of 
liver transplantation.26-31 
graft atrophy in auxiliary 
In our series no 
complications occurred, which were related to the fact 
that only a portion of the liver was transplanted, and 
the transplants functioned well enough to sustain 
long-term survival of good quality. This is demonstrated 
by the body-weight profiles. 
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Consequently, orthotopic nonauxiliary homo-
transplantation of 60% of a donor liver, including 5 hr 
of ischemia, is technically feasible in immunosuppressed, 
tissue-typed 
good -quality 
identical littermate beagles. The long-term 
survival is reproducible. In surviving 
recipients the graft does not atrophy and functions in 
much the same way as the liver remnant in vascular 
exclusion experiments. 
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Discussion following the 
1982 meeting of the 
Association. 
presentation of the paper at the 
American Pediatric Surgical 
E. Fonkalsrud (Los Angeles): Fifty percent survival 
for 6 rno with an orthotopic canine liver homograft is 
perhaps the best reported in the world literature thus 
far. I would like to ask Dr. Bax how he avoids some of 
the serious problems that others have encountered with 
coagulopathy after placing a homograft in the canine 
model. The studies presented here today perhaps take on a 
little greater significance now that cyclosporin-A and 
other new immunosuppressive regimens have reduced the 
incidence of rejection. Liver transplants are now being 
done more frequently than they were a few years ago, with 
increasing success. Could you give us some estimate, Dr. 
Bax, of the function of the liver grafts that you have 
transplanted? Do you see, for example, reasonably normal 
alkaline phosphatase, SGOT, and bilirubin levels? Some 
authors have indicated that when one takes a large organ 
from an adult and places it in an infant, there are 
certain physiologic problems with the blood supply. 
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For example, the mean blood pressure for an adult may be 
somewhere around 110-130, whereas in the infant who might 
be the recipient the mean blood pressure might be only 
50-60. The liver is particularly sensitive to changes in 
blood pressure and I wonder if you can conceive of any 
problems that this might cause in the studies that you 
have carried out in which a liver is transferred from an 
adult dog to another adult model. It would be of interest 
to transplant an adult liver into a puppy to simulate 
more closely the clinical situation posed by the authors. 
N.M.A. Bax (closing): No complications were related to 
the use of a partial liver. Premobilization cooling 
avoids inadvertant hypoperfusion and warm ishernic damage 
of the graft. The precarious blood supply of the donor 
common bile duct, preservational damage, autolysis by 
bile, infection by stasis, and rejection all play a role 
in the etiology of biliary complications and have to be 
dealt with, for example by trimming the common bile duct 
until good 
hemorrhagic 
occurred 
bleeding is 
diathesis, 
obtained. 
though never 
Dr. Fonkalsrud, 
uncontrollable, 
in most experiments, starting before 
revascularization and coinciding with a major drop in the 
platelet count. Clotting-factor activities dropped only 
after revascularization, intensifying the blood loss. 
Concomitant with a rise in the platelet count during 
further surgery, the bleeding ceased in spite of 
persistent low clotting-factor activities. A more optimal 
bypass might have prevented 
extent. The transaminase 
revascularization but had 
these 
levels 
largely 
events to a large 
rose sharply after 
normalized by the 
fourth day. The alkaline phosphatase levels took longer 
to recover. I do not think that a partial adult graft in 
a child will be hypoperfused, because that graft will 
receive the total hepatic blood supply of that child. 
Moreover, the portal venous system is a low pressure one, 
irrespective of age. 
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CHAPTER 8. PEROPERATIVE COMPLICATIONS 
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Summary 
The peroperative complications in a series of 20 
canine liver transplantations and 10 control experiments, 
using partial livers, are described. The same protocol 
for peroperative management was used for both surgical 
groups. All dogs survived the procedure. The most 
important changes occurred during the one- hour anhepatic 
phase of the operation and were related to insufficient 
decompression of the infradiaphragmatic venous systems 
despite use of a bypass rather than to the absence of the 
liver. Although severe hypotension and disturbance of the 
could be prevented, congestional acid-base 
bowel and 
balance 
renal damage occurred in all cases. 
The sharp reduction of the number of circulating 
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platelets during the anhepatic phase, which appeared to 
initiate the observed hemorrhagic diathesis, may well 
have been related to 
infradiaphragmatic venous 
groups behaved similarly, 
the congestion in the 
systems. The two surgical 
which implies that these 
changes were not due to immunological factors. Nor can 
these changes be attributed to the use of partial instead 
of total livers, since these changes occurred during the 
anhepatic phase. It is concluded that the degree of 
decompression of the infradiaphragmatic venous systems 
achieved during the anhepatic phase, at least in dogs, 
has repercussions on not only the hemodynamics but also 
on coagulation. The use of a partial instead of a total 
liver did not seem to require any modification of the 
peroperative management. 
Introduction 
Liver transplantation, particularly during the 
anhepatic phase,has been called the acme of liver disease 
management. 1 After years of animal and human liver 
transplantation, a number of guidelines for peroperative 
management have emerged. For adjustment of these 
guidelines, fully standardized animal experimental work 
is needed. The purpose of the present study is to assess 
the peroperative complications that occurred in a 
standardized series of canine liver transplantation 
experiments, using partial livers. 
Material and methods 
All experiments were conducted in accordance with the 
laws of The Netherlands governing animal experiments. The 
animals were male beagle dogs from an outbred colony. The 
mean age at operation was 481 (SD 78) days and the mean 
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body weight 12.8 (SD 1.9) kg. 
Thirty experiments were performed. Twenty dogs 
received 60% of a donor liver orthotopically and ten dogs 
were given a control operation consisting of vascular 
exclusion and cooling of the liver in situ, a 40% partial 
hepatectomy, and revascularization of the liver remnant. 
During the anhepatic phase, which lasted 53 (SD 4) 
minutes in the transplantation and 70 (SD 5) minutes in 
the control experiments, decompression of the 
infradiaphragmatic venous 
femora- and porto-jugular 
systems was achieved by a 
bypass. Total liver ischemia 
lasted 308 (SD 19) and 70 (SD 5) minutes in the 
transplantation and control groups, respectively. The 
control group was used to study the effects of surgical 
trauma and liver ischemia on the outcome in the absence 
of immunological factors. Surgical details have been 
published elsewhere. 2 
The same anesthesiological protocol was used for both 
groups. On the day before surgery, the regular kennel 
diet was replaced by a liquid diet. At 5 p.m. all 
leftover food was removed, leaving only water. 
Premedication consisted of i.m. fentanyl 0.01 mg per kg, 
dehydrobenzperidol 0.5 mg per kg, and 
per kg. After induction of anesthesia 
0.02 rng per kg and subsequent muscle 
atropine 0.02 mg 
with i.v. fentanyl 
relaxation with 
pancuronium 0.1 
was inserted into 
with a Siemens 
mg per kg, a cuffed PortexR tube nr. 9 
the trachea and artificial ventilation 
900R ventilator was started. The 
end-expiratory co 2 volume concentration was determined 
with a MeinhardtR capnograph. A tidal volume of 24 ml per 
kg at a rate of 
inspiratory-to-expiratory 
2-to-1 N2o-o2 gas mixture. 
12 per minute and an 
ratio of 1 to 2 were used for a 
The dogs were put on a warm-water mattress in a supine 
position. Two infusion systems were connected to a right 
cephalic vein cannula, one for a 4.2% NaHC0 3 solution 
given at an hourly dosage of 4 ml per kg body we.ight and 
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the other for a solution containing 112.5 mmol KCl and 80 
mmol glucose 
ml per kg body 
per liter given at an hourly dosage of 8.5 
weight. A left cephalic vein cannula was 
kept open with lactated Ringer's solution at a rate of 5 
drops per minute. This cannula served for the 
administration of any additional fluids. A nasogastric 
tube, esophageal temperature probe, urine catheter, and 
intradermic ECG electrodes were inserted. The right 
external jugular vein and right femoral artery were 
cannulated for pressure measurements and for blood 
sampling. A 1.18% NaCl, 3.4% glucose solution containing 
2 U heparin per ml was used for flushing of the central 
lines. The dogs were not heparinized during the anhepatic 
phase. 
At the start of the operation enflurane was given in a 
concentration of l%, but during surgery this 
concentration was gradually reduced to 0.6%. At the 
beginning of the anhepatic phase and again at 
revascularization of the liver, enflurane administration 
was temporarily stopped. When muscle relaxation was 
needed, pancuronium was given i.v. in a dose of 0.05 mg 
per kg. All dogs received 10 ml per kg fresh packed cells 
immediately before and 20 rnl per kg fresh plasma 
immediately after the start of the anhepatic phase. 
Additional plasma as well as lactated Ringer's solution 
were rapidly infused in the event of hypotension. At the 
end of the anhepatic phase fresh blood was brought into 
readiness to cope with any major loss of blood after 
revascularization. Per 100 rnl citrated blood or blood 
components, 1 rnl Ca c1 2 10% was slowly injected. 
After surgery, the dogs were kept anesthetized until 
rewarming up to 36°C had been effected. Persisting muscle 
relaxation was reversed with prostigmine 0.05 rng per kg 
i.v. under cover of atropine 0.025 rng per kg i.v. 
Enflurane and N2o were stopped and extubation was carried 
out in the dog's preheated cage. A hypodermic infusion of 
20 ml glucose 10% containing 1.5 mmol KCl per kg was 
100 
administered. One cephalic vein cannula was sealed off 
and left in situ till the next morning for intravenous 
fluid administration, if required. 
Blood sampling and observation 
standardized time-points during 
experiments (Table 1). 
recording were done at 
the course of the 
Table 1. Time-points of blood sampling and observation recording. 
0 =bose line (no starvation, anesthesia, or surgery) 
1 =under premedication, before induction of anesthesia 
2 = 10 minutes after the start of surgery 
3 ""30 minutes after the start of surgery 
4 = 60 minutes after the start of surgery 
5 =immediately after the start of the anhepatic phase 
6 =immediately before the end of the anhepatic phase 
7 = 30 minutes after revascularization 
8 = at the end of surgery 
9 =at the end of the anesthetic period 
10 = 3 hours after the end of the anesthetic period 
11 = 9 a.m. on the day after surgery 
12 = 4 p.m. on the day after surgery 
13 = 9 a.m. on the 4th day after surgery 
For points 2- 9 sampling concerned arterial blood, points 0- 1 and points 10- 13 venous blood. 
Statistical analysis 
The significance of the changes observed within each 
group was tested with the rank sign test at P < 0.05. 
Significant changes are indicated by a plus sign and 
non-significant ones by a minus sign in the Tables and 
Figures. Differences in changes between the two groups 
were assessed with Wilcoxon's test, also at P < 0.05. 
Significant differences between the two groups are also 
indicated (0) in the Figures and Tables. 
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Results 
Survival 
None of the transplanted or control dogs died during 
surgery and all but one dog awoke promptly at the 
conclusion of the anesthetic period. One control dog was, 
however, prematurely extubated and developed a 
respiratory and then cardiac arrest. Although 
resuscitation was successful in re-establishing cardiac 
action and spontaneous breathing, severe neurological 
damage had occurred and the dog was killed the next 
morning. 
Duration of anesthesia 
The mean duration of the periods under anesthesia is 
given for both groups in Table 2. For the transplanted 
group the preanhepatic surgical time includes the time 
needed for bench surgery on the donor liver, which was on 
average 32.25 (SD~ 7.46) minutes. For the control group 
the duration of the 
minutes longer than 
anhepatic 
for the 
phase was taken about 20 
transplanted group as a 
debatable compromise for the shorter total ischemic time 
of the liver in the control group. In the latter group 
the durations of the anhepatic phase and of liver 
ischemia were obligatorily equal. The longer 
postanhepatic surgical time in the transplanted group is 
explained by the need for an arterial anastomosis in this 
group. The greater_ loss of blood in this group also 
contributed to the duration differences. The time needed 
to bring the dogs up to temperature after surgery was 
about the same in both groups. 
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Table 2. Duration of anesthesia (mean in minutes~ 1 SD),not including the period under 
premedication. 
transplanted dogs control dogs 
pre-surgical 25.70 + 6.56 23.40 + 5.37 
- preanhepatic 139.15+12.23 115.60::!: 12.03 
surgical - anhepatic 53.05 + 4.47 70.40 + 5.73 
- postanhepatic 141.85 + 13.47 101.60 + 13.65 
post-surgical 82.25 + 24.74 84.50 ~ 25.76 
total 442.00+35.50 395.50 + 21.40 
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Body temperature 
As 
the 
shown in the 
temperature 
body-temperature 
dropped by 
profiles 
about 2°C 
(Fig. l), 
during 
premedication. During 
temperature and the 
surgery, 
use of a 
in spite of a high room 
warm-water mattress, the 
body temperature dropped 
decline during the 
progressively and with 
anhepatic phase, when 
a sharper 
the 4°C 
transplant was inserted or the liver of the control dog 
was cooled in situ. 
c• PREANHEPATIC i ANHEPATIC POSTANHEPATIC 
T 
" 
" 
" 
" 
c ::j 
,j 
"1 
32J 
" " TIME-POINTS 
Fig, J. Body temperature ( meon:!: J SD), 
The body temperature dropped about 2°C during the period under premedicationr further 
during surgeryr and more shorpfy during the onhepotic phose. 
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Artificial ventilation 
At the described ventilator settings, only minor tidal 
volume adjustments were required occasionally. The blood 
and the end expiratory co2 volume concentration 
showed a transient decrease at the beginning of the 
anhepatic phase, but then increased to reach peak values 
30 minutes after revascularization (Fig. 2). 
PREANHEPATIC ANHEPATIC 
T 30-i 
J END EXPIR CO, "'''',:l t-~ 
c ;o 
t---+li L--+---1--1--
END EXPIR GO, 
VOL% 7] 
l:j 
" " TIME-POINTS 
Fig. 2. Blood pC02 and end expiratory C02 volume concentration (mean 2: 1 SD). 
Blood samples 2- 9 were arterial blood, the others were venous blood. 
The arterial pCO:! and the end expiratory C02 volume concentration decreased at the 
beginning of the anhepatic phose and then increased reaching peak values 30 minutes after 
revascu larizoti on. 
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Hemodynamics 
The mean pulse rate and the mean systolic as well as 
the mean diastolic arterial pressure throughout the 
preanhepatic, anhepatic, and postanhepatic phases are 
given in Table 3, which also shows the mean 
the first blood-pressure recordings made 
anhepatic and postanhepatic phases. It is 
values for 
during the 
evident that 
there was a slight increase in the mean pulse rate at the 
close of the preanhepatic phase, whereas the mean 
systolic arterial pressure decreased slightly. The mean 
diastolic arterial pressure decreased only in the 
postanhepatic phase. All with-in group changes reached 
significance but the between-group changes did not. 
The mean of the first arterial pressure recordings 
during the anhepatic and postanhepatic phases did not 
differ from the mean for the entire corresponding period 
with the exception of the mean of the first systolic 
arterial pressure values in the postanhepatic phase in 
the transplantation group, which was significantly lower. 
Again, differences between the groups were not 
significant. 
An isolated drop in the arterial blood pressure during 
the anhepatic phase sometimes occurred because of 
accidental kinking of the bypass. Severe prolonged 
hypotension occurred in 
systolic blood pressure 
only 
fell 
one dog, a control whose 
from 140 to 60 mmHg at the 
start of the anhepatic phase. After about 20 minutes of 
rapid fluid loading with plasma and lactated Ringer's 
solution, the systolic blood pressure rose to about 100 
mmHg and then remained at that level. 
There were no major changes in the central venous 
pressure, even when overt bypass dysfunction occurred. 
Evidence of suboptimal decompression of the 
infradiaphragmatic portal and systemic venous systems was 
seen in all experiments. Although the use of a bypass 
during the anhepatic phase together with fluid loading 
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Table 3. Hemodynamic monitoring 
pulse rote per minute blood pressure in mmHg 
systolic diastolic 
T c T c T c 
preanhepotic 
mean of oil values 149.50 139.60 151.20 151.00 103.05 105.20 
SD 17.72 10.26 11.45 13.84 10.85 13.29 
an hepatic 
mean of all volues 167.35+ 153.20+ 145. 05+ 137.40+ 104.85 97.10 
SD 14.98 10.26 16.55 18.62 12.77 14,88 
mean of first volues only 144.35 136.00 - 108.50 - 98.60 -
SD 18.46 32.64 15.13 23.60 
postonhepotic 
mean of all values 163.15 155.30 - 147.40 145.10 - 92.80+ 89.50+ 
SD 14.90 13.88 17.26 5.87 14.40 10.73 
mean of first values only 129.50+ 138.50 - 84.25 - 84,80 
SD 29.55 23.69 25.09 25.19 
T =transplanted dogs 
C = control dogs 
+ =significant, - =not significant (rank sign test, P<0.05). 
The mean of all values for a given phase was compared with that of the preceding phase, 
whereas the mean of the first recordings wos compared with that of all values for the some phase. 
(Application of Wilcoxon's test to both groups showed no significant differences). 
and enflurane withdrawal prevented prolonged hypotension, 
urine production virtually ceased during the bypassing 
period (Table 4) and 
contained increasing 
the subsequently produced urine 
amounts of blood and protein. 
Concomitantly, there was a transient increase in the 
serum creatinine level (Fig. 3) • The absence of a 
corresponding increase of BUN may have been due to the 
absence of the liver, since in dogs BUN is produced 
exclusively by this organ. 3 During the bypassing period 
the bowel and spleen always became slightly engorged, and 
all dogs passed a loose stool mixed with some blood upon 
awakening. 
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eo CREAT 
;o 
PREANHEPATIC ANHEPATtC P STANHEPATI 
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m molll 
12 13 
TIME-POINTS 
Fig. 3. Serum creatinine and blood urea nitrogen (mean_:!: 1 SD). 
The serum creatinine values increased by the end of the onhepatic phose in the absence of 
o concomitant increase in the BUN values. 
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Fluid balance 
The intake and output of fluid are shown in Table 4. 
The two groups of dogs received the same amounts of the 
standard, NaHCo 3 and lactated Ringer's solutions. A 
larger amount of blood was given in the transplantation 
group. Urine production was similar in the two groups and 
showed a 
phase. 
significant 
Table 4. Fluid balance. 
INTAKE 
maintenance fluid (per kg per hour) 
standard solution 
NaHC03 4.2% 
total 
No+ 
K + 
Cl 
NaHC03 
glucose 
extra fluid (per kg) 
packed cells 
plasma 
lactated Ringers' solution 
total 
OUTPUT 
urine ( per kg per hour) 
preanhepati c phase 
anhepatic phose 
postanhepotic phose 
total 
reduction during the anhepatic 
transplantation group 
mean + 1 SD 
7.02ml+ 0.78 
2.83 ml + 0.59 
9.86 ml + 0,59 
1.41 mmol 
0.82 
0.82 
1.41 
0.56 
mean + 1 SD 
29.0 ml +10.0° 
35.9 ml+12.9° 
21 .2 ml + 6.7 
86.2 ml + 23.8 ° 
mean + 1 SD 
3.70 ml + 1.71 
0,94 ml + 1.12 
5.35 ml + 3.29 
3.94ml+ 1.83 
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control group 
mean + 1 SD 
6. 90 ml + 0.47 
3.04 ml + 0.43 
9.95 ml + 0.67 
1.52 mmol 
0.81 
0.81 
1.52 
0.56 
mean + 1 SD 
16.0 ml + 5.8 ° 
25.2 ml + 13.3 G 
19.6 ml + 14.6 
61.0 ml+30.0° 
mean ± 1 SD 
3.10 ml + 1.06 
0.97 ml + 0.61 
7.05 ml + 3.10 
3.90 ml + 1.15 
Acid-base balance 
All blood samples were analysed at 37°C. No gross pH 
changes were observed (Fig. 4). The initial rise of the 
base excess values is in all probability related to the 
fact that after the induction of anesthesia, arterial 
blood was analysed instead of venous blood (Fig. 5) • The 
base excess values remained relatively constant during 
surgery. At the end of the operation and during the early 
postoperative hours there was, however, a relative 
increase of the pH and base excess values (Figs. 4 and 
5). 
I PREANHEPATIC ANHEPATIC POSTANHEPATIC 
T "j lt--t-ti---t--1-J__J/ {fi 
"1 
C n-~ L~--+-+-----\-__ 
n1H/ 
' 
,J 
10 11 
TIME-POINTS 
Fig. 4. Blood pH (mean,! 1 SD). 
Samples 2- 9 were arterial blood, the others were venous blood. 
The pH level was maintained well during surgery but showed a relative increase at the end 
of the operation and in the early postoperative period. 
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PREANHEPATIC ! ANHEPATIC POST ANHEPAT•C: 
Fig. 5. Base excess (mean:!:: 1 SD). 
Samples 2-9 were arterial blood, the remaining ones were venous blood. 
During surgery the base excess values were slightly above normal and even higher values 
were seen at the end of the procedure and during the early postoperative course. 
Serum sodium and potassium changes 
The serum sodium values remained within a range of 140 
to 150 rnmol per liter. The serum potassium values rose 
during the anhepatic phase and reached peak values at the 
end of that phase. No electrocardiographic changes were 
observed. After the anhepatic phase the serum potassium 
levels dropped and tended to lie slightly under the 
base-line values in the early postoperative period (Fig. 
6) • 
lll 
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Fig. 6. Serum potassium (mean! 1 SD). 
T 
c 
The serum potassium values increased during the onhepatic phose but no increase occurred 
after revascularizotion. 
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Fig. 7. Blood glucose ( meon! 1 SD). 
Hyperglycemia occurred consistently throughout the procedure ond there was no increased 
glucose need during the onhepotic phose. 
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Blood-sugar changes 
Despite the administration of only small doses of 
glucose, 
consistently 
blood-sugar 
phase and 
hyperglycemia and glucosuria occurred 
throughout the anesthetic period. The 
levels did not decline during the anhepatic 
peak levels were measured shortly after 
revascularization (Fig. 7). 
Serum total protein changes 
The serum total protein content declined progressively 
during the operation. During the anhepatic phase a slight 
increase or a plateau 
administration (Fig. 8). 
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Fig. 8. Total serum protein (mean:!:: 1 SD). 
was seen 
POSTANHEPATIC 
after plasma 
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9 10 11 12 1] 
TIME-POINTS 
The progressive decrease during the procedure was interrupted by a slight increase or 
plateau after plasma administration during the onhepotic phase. 
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Hemostasis and coagulation 
Clinical evidence of hemorrhagic diathesis was found 
in all experiments,but the signs were most pronounced in 
the transplantation group. At the end of the anhepatic 
phase the incisions started to ooze, but the loss of 
blood, which was diffuse, only became important shortly 
after revascularization of the liver. During further 
surgery the loss of blood decreased progressively and had 
always stopped by the end of the anesthetic period. 
Concomitantly, marked changes in the platelet count 
were observed. The anhepatic phase showed a rapid and 
major decrease, the lowest counts occurring at the end of 
the phase in controls and 30 minutes after 
revascularization in transplanted dogs. At the end of the 
operation a relative increase of the platelet count 
occurred {Fig. 9). 
For the monitoring of the coagulation activity during 
the experiments, use was made of NormotestR. 4 This test, 
designed for coagulation assessment in man, measures the 
combined activity of factors II, VII, X, and, possibly, 
factor IX. In healthy beagles it gives extremely short 
coagulation times, which makes the sensitivity of the 
test too low. However, dilution of the canine plasma 
samples by a factor of three with Veronal buffer 
containing citrate in the same concentration as in the 
undiluted plasma gave a "modified" Normotest coagulation 
time of about 23 seconds, which corresponds with a normal 
or 100% value for human plasma. With this modification, 
the test was found to be sufficiently sensitive, covering 
levels between 20% and 120%, Compared with the 
preanesthetic values, the preanhepatic phase showed a 20% 
decrease occurring progressively. During the anhepatic 
phase the administration of fresh plasma was followed by 
an increase of about 5%. Shortly after revascularization, 
the values dropped further and no increase was observed 
during the rest of the operation. The lowest values were 
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Fig. 9. Platelet count (mean_! 1 SO). 
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A strong and progressive drop in the number of circulating platelets occurred during the 
anhepotic phose. The lowest counts were noted 30 minutes after revoscularizotion in the 
transplantation group and at the end of the onhepatic phose in the control group. 
I PREANHEPATIC ANHEPATIC POSTANHEPATIC I 
10 11 12 13 
TIME-POINTS 
Fig. 10. "Modified Normotest" results (mean_! l SD). 
The progressive decrease during the procedure is apparent. A small increase followed 
plasma administration in the anhepotic phose. The lowest values were found on the 
morning after the operation. 
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measured the morning after the operation (Fig* 10)§ 
Discussion 
All but one of the dogs regained consciousness 
promptly at the end of the period under anesthesia, thus 
confirming the beneficial value of the peroperative 
management protocol used. Under premedication the dogs 
were easy to handle but the body temperature decreased by 
about 2°C, which means that more attention should have 
been paid to the temperature of the environment. During 
surgery the body 
progressively, as 
temperature 
reported 
continued to decrease 
for clinical liver 
transplantation.5,6 
An inhalation type of anesthetic agent was chosen 
because this category permits quick adjustments. 
Enflurane was used because no major hepatotoxic effect 
has been reported for this drug. 7 However, the choice of 
the anesthetic agent seems less important than the 
peroperative management and the surgical technique as 
factors, affecting the over-all outcome* 8 
Unlike Popescu, we do not feel that the beagle is 
difficult to ventilate correctly.9 With the described 
ventilator settings, adjustments were rarely required~ 
Like Popescuv we too observed a decrease in the end 
expiratory co 2 volume concentration during the anhepatic 
phase. 10 At the same time there was a small decrease in 
the arterial Since these changes occurred 
immediately after the start of the anhepatic phase and 
normalized spontaneously during the rest of that phase, 
they cannot be ascribed to the absence of the liver or 
hypothermia. The changes in the venous return to the 
heart may offer a better explanation. At the start of the 
anhepatic phase 
were temporarily 
the infradiaphragrnatic venous 
occluded for the insertion 
systems 
of the 
bypass, and this reduced the venous return considerably. 
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Release of the bypass clamps restored the venous return 
at least partially. Because some degree of congestion in 
spite of the bypass was unavoidable, it may be assumed 
that the mobilization of stagnant blood after removal of 
the bypass was responsible for the postrevascularization 
increase in the capnographic and arterial pco2 readings. 
The intravenous fluid regimen we used is susceptible 
to criticism from various points of view. In the first 
place, substantial plasma losses into the peritoneal 
cavity occurred from the beginning of the operation, as 
reflected by the progressive decrease of total serum 
protein in the absence of changes in hematocrit values. 
Therefore, the systematic administration of fresh frozen 
plasma from the beginning of the operation, as advocated 
by Fortner, 1 1 seems recommendable, and might have 
prevented the preanhepatic prolongation of the 
coagulation time. 
On the basis of the canine studies done by Popescu, 
who found some of the deaths to be related to 
hypokalemia, 
procedure. 12 
potassium was given throughout the 
Even though electrocardiography showed no 
toxic effects, the serum potassium levels invariably rose 
during the anhepatic phase, as observed in human liver 
transplantation.6 This phenomenon can be explained by an 
insufficient infradiaphragmatic venous decompression 
resulting in impaired kidney function and portal venous 
congestion. During acute total portal vein occlusion in 
the dog the 
rapidly, 13 
serum potassium levels are known 
which makes it seem unwise to 
to rise 
continue 
potassium administration during the anhepatic phase. 
Since a venous base deficit of about 5 rnmol per liter 
is normal in nonfasting, nonanesthetized dogs, it can be 
concluded that the dogs were in a relatively alkalotic 
state during most of the procedure. This raises questions 
about the need for routine continuous administration 
of large amount of sodium bicarbonate. 
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In human liver transplantation, the policy of using 
large amounts of sodium 
discredited. 8 
bicarbonate has already been 
In the initial period 
transplantation large amounts of 
administered, especially during 
This policy was based on 
of orthotopic liver 
exogenous glucose were 
the anhepatic phase.l 4 
the knowledge that 
hepatectomized dogs usually die from hyperglycemia in the 
early postoperative period,lS and that hypoglycemia is a 
common finding in acute liver failure in man. 16 Later, it 
was recognized that hypoglycemia was a consistent finding 
during human liver 
anhepatic period, 
transplantation, even during the 
and that the degree of 
posttransplantation hypoglycemia was related to the 
quality of the donor liver.6,8 Although small amounts of 
glucose were 
hyperglycemia 
given 
was a 
in the 
consistent 
present experiments, 
finding even during the 
anhepatic phase. Therefore, less glucose should have been 
given, and perhaps none at all. 
Pathological bleeding remains a common and serious 
problem in clinical and experimental liver 
transplantation.6,8,1?-19 The most important factor in 
the severity of the bleeding is said to be the quality of 
the donor organ;20 the preoperative coagulation status of 
the recipient plays a far less important role.l9 However, 
little is known about the pathogenesis of the bleeding 
disorder. In this series of experiments the course of the 
hemorrhagic diathesis was closely related to the changes 
in the platelet count. The sharp decrease of the platelet 
count during the anhepatic phase marked the onset of the 
hemorrhagic diathesis which became clinically manifest at 
the end of the anhepatic phase in spite of a reasonable 
coagulation time at that time. Compared with the control 
group, the transplantation group showed a significantly 
lower platelet count 30 minutes after revascularization. 
This phenomenon, together with the much greater loss of 
blood after revascularization in the transplantation 
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group, might be related to the difference between the 
preservation time of the liver in the two groups. But a 
greater loss of blood and consumption of platelets can be 
anticipated in the transplantation group, because more 
vascular suturing was needed in this group. During futher 
surgery a gradual cessation of the 
accompanied by a rise of the platelet 
bleeding was 
count despite a 
further prolongation of the coagulation time. According 
to Groth and BOhmig, the platelet-count drop during 
orthotopic liver transplantation is due mainly to the 
induction of platelet aggregation and intravascular 
coagulation within the graft.l?,l9 In the present study, 
however, the 
closely to 
platelet-count decrease was 
the anhepatic phase 
related 
than to 
more 
the 
revascularization 
destruction of 
of the liver. 
platelets in 
Trapping and perhaps 
the insufficiently 
decompressed infradiaphragmatic venous 
responsible for this phenomenon. Our 
systems might be 
findings suggest 
that the course of the hemorrhagic diathesis is related 
to changes in the platelet-count rather than to changes 
in the coagulation activity. It is not known whether the 
administration of platelet concentrates during the 
anhepatic phase, which is current practice in human liver 
transplantation, would have 
hemorrhagic diathesis seen in 
Many of the peroperative 
changed the 
our study. 8 
difficulties 
course of the 
we encountered 
seemed to reflect insufficient decompression of the 
portal and systemic infradiaphragmatic venous systems. 
Although less pronounced and not lethal, the changes 
observed during the anhepatic phase resembled those seen 
during canine total portal13 , 21 and suprarenal caval vein 
occlusion.2 2 Similar changes also occur during clinical 
liver transplantations where no bypass is used. Although 
in man bypassing is stated to be unnecessary 
dangerous, 23 congestion undoubtedly occurs 
and even 
in the 
infradiaphragmatic venous 
effects of clamping of 
systems. Furthermore, 
the infradiaphragmatic 
the 
venous 
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systems in the absence of a bypass are poorly tolerated 
by patients without preexistent portal hypertension. 
For such cases the use of a partial cardiopulmonary 
bypass has been advocated. 24 The systematic use of a safe 
and effective bypassing system might therefore avoid many 
of these problems and thus render orthotopic liver 
transplantation a much less risky form of treatment. 
The peroperative complications cannot be ascribed to 
immunological factors, because the transplantation and 
control groups behaved similarly. 
The use of a partial instead of a total liver did not 
seem to require any modification of the peroperative 
management. 
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CHAPTER 9. VASCULAR AND BILIARY COMPLICATIONS 
9.1. Vascular complications 
9.1.1. Methods of diagnosis 
Vascular complications were diagnosed angiographically 
and at autopsy. Pervenous angiography was performed 
routinely on the 4th and 11th postoperative days and 
additionally on indication. The technique used has been 
published and the text is reproduced here by permission. 
PERVENOUS HEPATIC TRANSPLANT ANGIOGRAPHY USING A NEW LOW 
OSMOLAR CONTRAST MEDIUM - AN EXPERIMENTAL STUDY IN DOGS -
N.M.A. Bax,l M. Meradji,2 and J.C. Molenaar. 1 
From the Departments of Pediatric Surgery, 1 and 
Radiology, 2 of the School of Medicine of Erasmus 
University, 
This study 
Rotterdam, The Netherlands. 
was financially supported by 
Foundation for Scientific Research. 
Published in Invest Radio! 17:299-304, 1982. 
Reproduced by permission. 
Summary 
the Sophia 
The patency of the vascular anastomoses in a canine 
liver transplantation model was imaged by serial 
pervenous angiography using ioxaglate, which is a new 
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ionic low osmolar contrast medium. No premedication or 
general anesthesia was administered. No major adverse 
reaction was noted, not even after repeated angiography. 
Except for the occurrence of one hematoma formation and 
one para venous injection which resolved without 
sequellae, no local complications occurred. Sufficient 
information regarding the patency of the hepatic artery 
anastomosis was obtained in 94% of the angiographic 
studies, and in 70% the patency of the caval anastomoses 
could be determined. In addition, portal vein patency was 
imaged in 21% of the angiograms. Even better 
visualization results can be expected by combining this 
method with video subtraction techniques, although 
patient cooperation or general anesthesia would then be 
mandatory. 
Introduction 
Orthotopic liver transplantation involves one biliary 
and four vascular anastomoses. The biliary anastomosis is 
considered to be the Achilles' heel of liver 
transplantation,! and many complications have been 
reported. However, biliary anastomotic complications can 
easily be detected and interpreted by T-tube 
cholangiography. Surprisingly 
resulting 
reported 
from the vascular 
less frequently 
enough, complications 
anastomoses have been 
in clinical liver 
transplantation, but the patency of the various types of 
vascular anastomosis was not monitored routinely. In 
contrast, an incidence of hepatic artery thrombosis of up 
to 38% has been reported in canine liver transplantation, 
in studies where the arterial 
angiographed on a more routine basis.2 
anastomosis was 
Whereas thrombosis of the allograft arterial supply 
results in the death of canine recipients within a few 
hours, the effects of arterial thrombosis in transplanted 
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children may be delayed for several days. What is more, 
the results of e.g. serum transaminase determinations or 
liver scans may well 
nondjagnostic until 
remain normal or at 
the situation has 
least 
become 
irreversible, and it is likely that aortography will 
prove to be the only really decisive way of consistently 
establishing the diagnosis while there is still time for 
repair.3 
Although accurate from the diagnostic point of view, 
classic arteriography has serious drawbacks mainly 
related to the need for arterial catheterization and to 
the hyperosmolality of the commonly used contrast 
media. 4-6 Since the injection is painful, premedication 
or general anesthesia is mandatory in children or 
laboratory animals such as dogs, which may be perilous in 
cases with poor graft function. Consequently, classic 
arteriography 
procedure. 
is unsuitable as a routine evaluation 
To evaluate the patency of the various vascular 
anastomoses, and particularly of the hepatic artery, in a 
new canine liver transplant model, use was made of a less 
invasive angiographic technique based on the principle of 
pervenous angiography but using a new contrast medium of 
lower osmolality. 
Methods 
Laboratory animals and surgical procedures 
The laboratory animals consisted 
predominantly beagles, of both sexes. 
of 38 
They 
dogs, 
were 
approximately 1 year old, and their body weight averaged 
12.7 kg, ranging from 6.7 to 15.3 kg. Twenty-five dogs 
received an orthotopic, partial liver transplant 
consisting of 60% of a donor liver, the left lateral and 
medial lobes having been removed. The venous anastomoses 
125 
were performed end-to-end. The donor hepatic artery with 
a celiac trunk patch was anastomosed end-to-side to the 
recipient celiac trunk once the 
had been disconnected (Fig. 1). 
recipient hepatic artery 
AFTER HEPATECTOMY AFTER TRANSPLANTATION 
.: ~ 
Lend to side 
anestomO$iS 
Fig. 1. Arterial anatomy in the recipient (lateral projection) after removal of the native liver and 
after insertion of the allograft. 
Thirteen 
operations 
circulaton 
which a 40% 
dogs had a sham operation. In these 
the liver was temporarily excluded from the 
by vascular clamping and cooled in situ, after 
partial hepatectomy was carried out. 
Revascularization was achieved by releasing the vascular 
clamps. The sham operations served to evaluate the 
combined effects of surgical trauma, liver ischemia, an 
anhepatic phase, partial hepatectomy, biliary 
anastomosis, and immunosuppressive therapy, on animal 
survival, liver function, and liver regeneration in the 
absence of an allograft. Even 
anastomosis was carried out in the 
13 dogs were subjected to pervenous 
though no vascular 
sham operations, these 
angiography as in the 
transplanted animals, in order to standardize procedures 
in both groups of dogs. 
126 
Contrast medium 
Use was made of a new ionic, water-soluble agent, 
ioxaglate, which has a monoacid, dimeric structure with 
six iodine atoms per molecule. In a concentration of 320 
mg iodine per ml, the osmolality amounts to 600 rnmol/1. 
Figure 2 summarizes the chemical structure and the 
physicochemical properties of the agent. 
CH, 
COO (basel 
HO-CH,-CH,-NH-CD
1 0 1NH-CO-CH,-NH-CO 
I 
N-CO-CH~ 
-iirl 
~ CO-NH-CH3 
Fig. 2. Chemical formula of ioxoglate ( Guerbet, Poris, France). 
Composition: 
molecular weight"' 1269 
salt content 
meg!umin salt 
sodium salt 
59 g% 
39.4 g% 
19.7 g% 
Radiologic technique 
iodine content ""32 g% 
viscosity at 37°C := 7.5 m Po s 
osmolality 
pH 
= 600 mmol/1 
"'6,5-7.6 
A gauge 16.50 rnm cannula (BraunulaR) was inserted into 
the cephalic vein and connected to an automatic pressure 
injector (Mark II Medrad, Inc.). A dose of 2.5 ml 
ioxaglate per kg body weight was injected in 4 seconds, 
and serial angiograms were taken at 0,6,8,10,12, 
seconds. 
and 14 
The dogs were not starved, 
anesthesia was administered. 
and no premedication or 
Because our main objective 
was the visualization of the celiac trunk and its major 
branches, a lateral decubitus positon was chosen. The 
dogs were kept in position on the table by two 
assistants, one holding the head and pelvis, the other 
holding the paws. The dogs were examined routinely on the 
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4th and the 11th postoperative days and, in addition, on 
indication. 
All experiments were conducted in accordance with the 
regulations on animal experiments as prescribed by the 
Netherlands' law. 
Results 
Pervenous hepatic angiography was carried out 79 times 
in 38 dogs and resulted in 70 examinations that were 
technically satisfactory (Table 1). 
Table 1. Assessment of pervenous angiography*. 
transplantation group 
control group 
total 
number 
of dogs 
25 
13 
38 
number of angiographic examinations 
total 
55 
24 
79 
technically satisfactory 
52 
18 
70 
* Pervenous angiography was carried out 79 times in a series of 38 dogs, resulting in 70 technically 
satisfactory examinations. In nine instances the angiographic examination did not succeed due to 
technical difficulties. 
In one instance, the dog was too aggressive to be 
examined and in another instance, the cephalic vein could 
not be cannulated as a result of multiple previous 
venipunctures. Hematoma formation at the cannulation 
site, paravenous injection, and cannula disconnection 
each occurred once. Defective X-ray apparatus was 
responsible for the remaining four failures. 
Seventy angiographic examinations were technically 
satisfactory.Each dog was examined one to five times 
(Table 2). An assessment of the quality of visualization 
of the main hepatic artery, the retrohepatic caval vein, 
and the portal vein is presented in Table 3. 
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Table 2. Specification of technically satisfactory angiographic examinations. 
number of angiographic number total number of 
examinations per dog of dogs angiographic examinations 
13 13 
2 20 40 
3 4 12 
5 5 
total 38 70 
Table 3. Ouality of visualization * 
transplantation group control group total 
adequate adequate adequate 
c c % c c % c c % 
hepatic artery excellent 
14} :t 17} good 30 51 98 15 83 39 66 94 medium 7 10 
poor 3 4 
caval vein excellent 
1:} J 1:} good 37 71 12 66 49 70 medium 19 29 
poor 15 6 21 
portal vein excellent ~} :} 1~} good 12 21 3 16 15 21 medium 
poor 40 15 15 
* Assessment of 70 pervenous angiographs of 38 dogs, a total of 52 angiogrophs in the transplantation 
group and 18 in the control group. Quality of visualization is termed adequate when sufficient for 
diagnosis, ranging from medium {sufficient for determining patency) to excellent. Poor 
visualization includes no visualization. 
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The classification ranged from poor (insufficient or 
no visualization) to excellent, and from medium upwards 
the quality was adequate in that it was sufficient for 
determining patency. In the 6- and 8-second angiographic 
examinations, the rate of successful visualization of the 
patency of the main hepatic artery was as high as 94%. 
Retrograde filling of the recipient gastroduodenal artery 
and the amputated hepatic artery was seen on the 
angiograms of the transplanted dogs. The superior 
mesenteric artery was also clearly visible as were the 
renal arteries, 
superimposition 
albeit 
of the 
in a lateral projection with 
renal parenchyma (Fig. 3). 
Thrombosis of the hepatic artery was easily detectable as 
shown in Fig. 4 and Fig. 5. A retrohepatic cavogram was 
obtained in 70% of the 10- and 12-second angiographic 
examinations, and delineation of the portal vein was in 
the range of 21% in the 12- and 14-second angiograms 
(Fig.6). 
On the whole, the dogs remained quiet during the 
injection of contrast media and the subsequent 
angiography procedure, though in a few instances there 
was some movement, resulting in partial blurring of the 
serial angiograms. There were two local complications, 
one hematoma and a para venous injection, but these 
resolved without sequellae; the paravenous injection had 
subsided completely within 24 hours. Mild vomiting 
occurred in two instances, without any lasting effect on 
the general condition or appetite of the dogs concerned. 
Apart from this, no adverse reaction occurred, not even 
in the dog that had just been transplanted or in the dog 
with poor liver function, despite multiple angiographic 
examinations. As a matter of interest, we may add that in 
two dogs, dosages up to 7.5 ml ioxaglate per kg body 
weight were administered without any adverse reaction. 
These nonoperated dogs were used in a few pilot 
experiments performed to standardize the radiographic 
method. 
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Fig. 3. Pervenovs angiogram at 6 seconds. 
The aorta, celiac trunk, and superior mesenteric artery are clearly visible. The transplanted 
hepatic artery has a dilated aspect, and retrograde filling of the gastroduodenal artery is 
visible (arrow). The renal parenchymas are seen in a superimposed lateral position. 
Fig. 4. Pervenous angiogram at 8 seconds. 
The transplanted hepatic artery shows a filling defect (arrow), The defect is not complete, 
since the distal artery is still visualized. Immediately caudal to the filling defect, the 
amputated retrograde-filled recipient hepatic artery con be seen. A cavogram was also 
obtained. At autopsy, the next day, the thrombus could be identified. 
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Fig. 5. Pervenous angiograms at 6 seconds. 
(A) The transplanted hepatic artery is not 
visible. At repeat laparotomy, the 
hepatic artery was opened and a 
thrombus was extracted. 
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(B) On a pervenous angiogram made the next 
day, restoration of the hepatic arterial 
blood supply is shown, although the site 
of the arteriotomy is narrowed (arrow). 
Note the transcholedochal splint, 
Fig. 6. Pervenovs angiogram at 12 seconds. 
While visualization of the arterial tree is fading, the retrohepatic caval vein shows vp as 
does the portal vein. 
Discussion 
The technique of pervenous arteriography 
It was first described by Robb and Steinberg 
is not new. 
in 1939.7 
Other reports followed,8-13 though the technique did not 
become widely accepted. The reason for this was that 
large quantities of strongly hypertonic contrast media 
had to be injected rapidly, which not only resulted in 
important hemodynamic changes, but also caused a great 
deal of pain during the actual injection. 4- 6 What is 
more, the visualizaton of the peripheral arteries was 
very poor. In order to improve the visualization of the 
peripheral arteries and slow down the rate of injection 
of highly hypertonic contrast media, the usefulness of 
xeroradiography has been tested, with promising 
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results. 14 More recently, video subtraction techniques 
have become available, renewing the interest in pervenous 
arteriographylS-19 as lower doses of the classic contrast 
media can be used. A requisite for satisfactory 
examination, however, is patient cooperation, which 
cannot be expected in small children or 
animals such as dogs. 
laboratory 
With the introduction of contrast media with lower 
osmotic concentration, new possibilities have arisen in 
pervenous arteriography. These products cause 
less-pronounced hemodynamic changes and considerably less 
pain reaction during injection, 20-25 reducing the need 
for premedication or anesthesia. While the osmolality of 
the classic agents at an iodine concentration of 320 mg 
per ml at least quadruples the serum osmolality, 26 this 
is only doubled when ioxaglate is used at an identical 
iodine concentration. Consequently, higher doses might be 
injected, improving the quality of the visualization of 
the blood vessels. Although patient cooperation would 
certainly improve the quality of the x-rays, satisfactory 
results can be obtained in an anxious dog without 
premedicaton or anesthesia. 
In combination with video subtracton techniques in the 
cooperative patient, further improvement in visualization 
can be expected, not only of the arterial but also of the 
venous phases and perhaps also of the portal circulation. 
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9.1.2. Results 
In the present series of experiments, 54 angiographies 
were performed,i.e, 37 in the transplantation group and 
17 in the control group. Five of these studies were 
performed on indication, all of them in transplanted 
dogs. The others were performed according to the 
protocol, on the 4th and 11th postoperative days. 
Vascular anastomotic problems occurred in one dog 
only. Hepatic artery thrombosis in this transplanted dog 
(T 6) was diagnosed on a routine angiogram on the 4th 
postoperative day, when no obvious clinical morbidity was 
present (Fig. SA). Patency was reestablished surgically, 
as confirmed by the angiographic study performed on the 
day after 
angiography 
thrombectomy (Fig. SB). However, the 
performed on the 11th day after 
transplantation confirmed the clinical suspicion of 
recurrence of thrombosis, and this was substantiated at 
autopsy on the 14th day after transplantation. 
All remaining anastomoses remained patent and stenosis 
did not occur. 
9.1.3. Discussion 
The angiographic and autopsy findings allowed correct 
determination of the vascular anastomotic complication 
rate. Since vascular anastomotic problems occurred in 
only one dog , it may be concluded that the surgical 
techniques used for the vascular anastomoses were 
satisfactory. It is of interest to mention that the 
initial diagnosis of hepatic artery thrombosis in the one 
dog that eventually died from this complication, was made 
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on a routine angiogram, on the 4th postoperative day, in 
the absence of obvious clinical morbidity. 
The described technique of pervenous angiography, 
using a low osmolar contrast medium, proved to be a 
valuable tool for the assessment of the patency of the 
hepatic artery and of the retrohepatic caval vein. 
However, patency of the portal vein could only be 
evaluated in 21% of the angiographic studies. In 
combination with digital video subtraction ~tter 
visualization can be expected, not only of the arterial 
but also of the venous phases and perhaps also of the 
portal circulation. 
9.2. Biliary complications 
9.2.1. Methods of diagnosis 
Biliary complications were diagnosed clinically, 
cholangiographically, and at autopsy. 
Cholangiographic studies were carried out routinely on 
the 32nd and 169th days after surgery and additionally on 
indication. Indications were: fever, jaundice or abnormal 
behaviour. In-vivo studies were performed under sedation 
with fluanisone in a dose of 3 mg per kg i.m. Studies on 
the 169th day were performed immediately after the animal 
was killed. All dogs were examined in a left lateral 
position on the X-ray table, and Conray 60R was used as a 
contrast medium. All studies on the 32nd day or earlier 
were carried out by percutaneous puncture of the 
subcutaneous end of the biliary splint. The same 
technique was used after sacrifice on the 169th day if 
the splint had not been removed; otherwise, a retrograde 
cholangiographic study was performed through the papil of 
Vater. Initially, all splints were removed after the 
routine cholangiographic study on the 32nd postoperative 
day, and this was the case for the first 7 transplanted 
138 
and the first 3 control dogs, but after one dog (T 7) 
died from biliary leakage and one (T 11) became 
permanently jaundiced after removal of the splint, it was 
decided to leave the splint in situ in the other dogs for 
the entire 
splints, had 
complications 
survival period. Nevertheless two more 
to be removed because of biliary 
(T 8, T 14): the first because of 
splint 
severe 
infection around the splint and the second because of a 
discrete, cholangiographically detected biliary leak from 
the lateral hole in the splint. 
The numbers and timing of the cholangiographic studies 
are given in Table 4. 
Table 4, Number and timing of the cholangiographic studies. 
transplanted dogs 
on indication (all percutaneously) 9• 
routinely 
on day 32 (all percutaneously) 14 
on day 169 10 
- percutaneously 7 
-via the papil of Vater 3" 
total 33 
5 dogs examined once each, 2 dogs examined twice 
control dogs 
9 
9 
6 
3 *** 
19 
total 
13 
6 
10 
23 
52 
one splint had been removed according to the original protocol, two because of splint-related 
complications 
***all three splints hod been removed according to the original protocol 
9 o 2 o 2 o Results 
Diagnosis on clinical grounds 
One dog (C 10) was reoperated on the first 
postoperative day because of fever, jaundice, and 
clinical signs of peritonitis. At laparotomy a leaking 
anastomosis was found and repaired. 
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Cholangiographic studies 
Studies on indication 
-----------
Nine studies were carried out in transplanted dogs, 
one each in five dogs and two each in two. In the former 
group, only one study gave abnormal results. In this dog 
(T 10) the biliary splint had shifted partially into the 
duodenum and the biliary tree was not visualized. The 
severe jaundice in this dog was explained by blockage of 
the papil of Vater by the splint. The splint was 
surgically repositioned and the jaundice cleared up 
rapidly. One of the dogs (T 3) had a normal cholangiogram 
on the first postoperative day, but at autopsy eleven 
days later was found to have had an anastomotic leak. The 
two studies in dog T 19 were normal, but in T 18 an 
anastomotic leak was documented cholangiographically on 
day 18. A repeat study performed three days after repair 
showed an irregular but non-leaking anastomosis. 
The only control dog (C 10) examined on indication had 
been reoperated for an anastomotic leak diagnosed 
clinically on the first postoperative day. Five days 
later a discrete leak was still present 
cholangiographically, but this leak healed spontaneously. 
~t~dle~ Qn_d~y_3l: 
On day 32, 14 transplanted and 9 control dogs were 
alive and available for study. The results of 12 of the 
14 studies in transplanted dogs, were normal. In one dog 
(T 14) a discrete leak from the lateral hole in the 
splint was seen and the splint was removed. Marked 
anastomotic narrowing was seen on the cholangiogram of 
T 18, which had undergone anastomotic repair on day 18. 
Two of the nine studies performed in the control group 
gave abnormal results. In one dog (C 3) visualization was 
not obtained due to occlusion of the splint. In the 
remaining dog (C 8) a narrowed right hepatic duct without 
proximal dilatation was seen. 
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~t~dle~ ~n_d~y_l6~: 
Two of the 19 studies gave abnormal results. In T 18, 
whose anastomosis had been repaired on day 18, the tip of 
the splint had become dislodged and was now in an 
intraperitoneal position. In control dog C 8, the known 
constriction of the right hepatic duct showed no change. 
All of the other studies gave normal results except for 
some narrowing at the anastomotic side, but without 
proximal dilatation. Even the transplanted dog, which 
became 
on day 
permanently 
32 (T ll), 
jaundiced after removal of the splint 
showed no obstruction on the 
cholangiogram obtained via the papil of Vater. 
Autopsy findings: 
Biliary 
dogs (T 
peritonitis was 
3, T 4, T 7, T 
present in four 
10). One dog 
transplanted 
(T 3) had an 
anastomotic leak. T 4 showed leakage from the lateral 
hole of the splint into the peritoneal cavity, due to 
dislodgement of the splint. T 7 developed leakage from 
the cystic duct stump after withdrawal of the splint on 
the 32nd postoperative day, and T 10 died from a 
peripheral bile-duct leak after a percutaneous biopsy 
procedure. 
In dogs 
anastomosis 
narrowing 
T 11, which 
the biliary 
surviving until the end of the study period the 
looked well healed at autopsy, and severe 
with proximal dilatation was not seen. Even 
became permanently jaundiced after removal of 
splint, showed no obstruction at autopsy and 
the cause for the jaundice was cholangitis as could be 
determined microscopically. 
Minimal biliary slush was found in one transplanted dog 
(T 18) and one control dog (C 7). 
The total biliary complication rate is shown in Table 5. 
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Table 5. Total biliary complication rate based on clinical, cholangiographic, and autopsy diagnosis. 
transplantation group control group 
fatality fatality 
n total n total n total n total 
anastomotic complications 3 2 0 
leakage 2 0 
stenosis 0 +1 0 
formation of slush (minimal) 0 0 
splint"'"reloted complications 7 2 0 
splint infection 0 0 0 
splint occlusion 0 0 0 
splint dislodgement 
- anterogradely 0 0 0 
-retrogradely +peritonitis 0 0 
-peritonitis 2 0 0 0 
after splint withdrawal 
-biliary leakage 0 0 
-biliary obstruction 0 0 0 
accidental biliary perforation 
0 0 (percutaneous liver biopsy) 
total 12 4 4 0 
992.3. Discussion 
The biliary reconstruction was the Achilles• heel of 
this experimental series too (Section 4.3). Leakage of 
the anastomosis occurred in two transplanted dogs and one 
control dog, giving an incidence of 10% for both groups. 
Only one transplanted dog died. The other two were saved 
by early diagnosis and prompt reintervention. 
Substantial stenosis at the site of the anastomosis did 
not occur, and minimal slush formation was seen at 
autopsy in only one dog of each group. 
Splint-related complications occurred frequently in the 
transplantation group and were responsible for the death 
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of two dogs. Moreover, there seems to have been a 
relationship between the presence of a 
the long-term biochemical as well 
histological findings, as will be 
biliary splint and 
as the long-term 
discussed below 
(Chapters 10 and 11). The use of an appropriately sized 
T-tube, left in situ for a long time as is done in 
clinical liver 
these problems. 
transplantation, might have prevented 
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CHAPTER 10. LIVER FUNCTION 
10.1. Clinical assessment 
Liver failure was the primary cause of death in two 
dogs, both belonging to the transplantation group: one of 
them (T 2) died from acute liver failure 24 hours after 
surgery and the other (T 9) was killed on the 39th 
postoperative day because of manifestations of chronic 
liver failure. In the latter an atrophied transplant was 
found at autopsy. In the other dogs death was due to 
other causes {Chapter 7). Most of the dogs that survived 
the period of the study did well clinically, as can be 
deduced from the over-all body weight changes during the 
survival period (Chapter 7). 
10.2. Biochemical assessment 
10.2 .l. Methods 
The levels of serum potassium, blood sugar, serum 
bilirubin, serum glutamic pyruvic transaminase (GPT), 
alkaline phosphatase, and serum albumin were determined 
at standardized time-points during the period under study 
(Table 1). 
Table 1. Timing of biochemical analysis. 
preoperatively at 9 a.m. on the 7th day before surgery. 
postoperatively at 9 p.m. on the day of surgery 
ot 9 o.m. on days 1, 4, 6, 11, 18, 25, 32, 46, 60, 74, 95, 123, and 151, 
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The elimination of two intravenously injected 
substances from the plasma by the liver was studied. The 
bromsulphthalein test is considered to be a sensitive 
indicator of liver function, at least in the absence of 
jaundice. Because bromsulphthalein is taken up by the 
liver cells, conjugated with glutathione, and excreted in 
the bile, the classic test does not discriminate between 
hepatocellular and cholestatic conditions. Due to the 
relatively high intrinsic clearance of the substance, the 
over-all clearance is dependent on the blood flow through 
the liver. Since a large proportion of injected 
bromsulphthalein binds to the plasma proteins, the 
distribution is 
volume. 1 -3 
largely determined by the plasma 
Antipyrine is considered to be an ideal substance for 
the study of liver metabolism. It is distributed rapidly 
and proportionally over the total body water, is almost 
totally and exclusively metabolized by the liver, gives 
very few side effects, and is relatively simple to 
determine in plasma samples. Because of its extremely low 
intrinsic clearance, the total clearance is to a great 
extent independent of the blood flow through the liver. 
The antipyrine clearance gives a good idea of the 
integrity of the 
hepatocyte. 2 ' 3 
microsomal enzyme system of the 
Bromsulphthalein and antipyrine elimination tests were 
performed preoperatively and 4, 18, 25, 32, 46, 60, 74, 
123, and 151 days after surgery. The dogs were starved 
the night before the test. At 9 a.m., bromsulphthalein 
was injected intravenously in a dose of 5 mg per kg body 
weight. Two-milliliter samples of venous blood were drawn 
into heparinized tubes at 0, 1, and 15 minutes. The 
samples were centrifuged and the plasma was stored 
at -20°C until analysed. The determination of 
bromsulphthalein in the samples 
according to 
was carried 
Seligson et 
out 
al. 4 spectrophotometrically, 
After completion of the bromsulphthalein test, antipyrine 
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was injected intravenously in a dose of 50 mg per kg body 
weight. Two-milliliter samples of venous blood were drawn 
into heparinized tubes at 0, 60, 90, 120, and 300 
minutes. The samples were centrifuged and the plasma was 
stored at -20°C until analysed. The determination of the 
antipyrine concentration in the plasma samples was 
carried out gas-chromatographically according to Prescott 
et al. 5 
10.2.2. Results 
Serum potassium 
During the first 24 hours after surgery, the serum 
potassium levels tended to be slightly below the 
preoperative values (Chapter 8). The lowest value during 
this period was 2.7 rnrnol per liter, the highest 5.1 rnrnol 
per liter. 
Blood sugar 
During the first 24 hours after surgery, values below 
3 rnmol per liter were found in two transplanted dogs and 
one control dog. The 
symptomatic in only one 
transplanted dog that died 
failure. 
Total serum bilirubin 
hypoglycemia 
of these 
at 24 hours 
was, 
dogs, 
due to 
however, 
i.e., the 
acute liver 
The total serum bilirubin levels are given in the 
Tables 2, 3, and 4. None of the preoperative levels were 
higher than 2 pmol per liter. 
A slight temporary rise of the levels during the 
first 24 hours after surgery was a common finding in the 
first 15 experiments, even in the absence of obvious 
biliary-tract pathology. Early high increases or 
increases which had not returned to normal by the 4th or 
6th postoperative day usually indicated biliary-tract 
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Table 2, Total serum bilirubin (,mol/1). 
Transplantation group: dogs dying before the I 69th day. 
pre- postoperative days 
opera- 0 l 4 6 11 18 25 32 46 60 74 95 123 151 
tively 9pm. 9am. 
T 1" 6 
2" 0 10 
3' 10 8 6 7 
4• 13 14 108 139 
5" 5 2 2 2 
6• 10 3 9 58 43 
r 0 4 
8 21 56 28 6 4 56 
9 112 
10 36 41 42 17 
T = transplanted dogs *=first 10 experiments 
Table 3. Total serum bilirubin (!-lmof/1), 
Transplantation group: dogs surviving for 169 days. 
pre- postoperative days 
opera- 0 4 6 II 18 25 32 46 60 74 95 123 151 
tively 9p.m. 9a.m. 
T J l * 5 4 2 0 4 47 109 95 72 86 
12" 2 2 2 2 2 2 
13• 5 7 2 2 2 2 2 
14 
15 
16 
17 
18 69 8 30 9 14 
19 44 17 4 
20 
T = transplanted dogs *=first 10 experiments 
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Table 4. Total serum bilirubin ( umal/1 ) . 
Control group. 
pre- postoperative days 
opera- 0 4 6 11 18 25 32 46 60 74 95 123 151 
tively 9 p.m. 9 a.m. 
C1 
2' 2 2 5 0 2 3 3 2 2 2 
3' 3 2 2 2 6 4 4 4 3 3 
4' 2 2 2 
5' 2 2 2 3 2 2 
6' 2 2 2 4 3 3 3 2 2 
7 7 11 
8 
9 
10 22 29 3 
C "" control dogs *"'first 5 experiments (with immunosuppressive treatment) 
pathology. In three transplanted dogs, (T 6, T 8, T 
19),however, 
demonstrated. 
no 
Dog 
biliary 
T 6 had a 
tract pathology could be 
thrombosed hepatic artery, 
which was diagnosed on a routine pervenous angiogram 
performed on the 4th postoperative day. At that stage 
only a small increase in the total serum bilirubin level 
was noted. Dogs T 8 and T 19 were febrile during the 
period of hyperbilirubinemia, suggesting an infectious 
etiology. T 8 subsequently developed wound infection 
and eventually died from lobar necrosis' of the graft. 
Elevated total serum bilirubin levels after the first 
two postoperative weeks were found in four transplanted 
(T 8, T 9, T 11, T 18) and two control dogs (C 3, C 7). T 
8 died from lobar 
biliary peritonitis 
necrosis 
after 
of the graft 
withdrawal of 
and T 9 from 
the biliary 
splint on the 32nd postoperative day. T 11 became 
permanently 
on the 32nd 
obstruction 
jaundiced after removal of the biliary splint 
postoperative 
was found 
day. 
but 
At autopsy on 
cholangitis 
day 169, no 
was seen 
histologically. T 18 developed a late leak at the site of 
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the biliary anastomosis, which was repaired. At autopsy, 
a subphrenic abscess was found. In the two control dogs 
which developed discrete hyperbilirubinemia (C 3 and 
C 7), no obvious cause was found. 
Serum liver enzymes 
The serum GPT and alkaline phosphatase levels are 
given in Tables 5-7 and 8-10, respectively. 
After revascularization, the GPT levels showed a sharp 
rise. Peak levels were noted at 9 p.m. on the day of 
surgery or, more often, at 9 a.m. on the next day. The 
rise was much higher in the first 15 experiments and more 
pronounced in the transplantation group. By the fourth 
postoperative day the levels had dropped markedly, and in 
most of the surviving dogs they continued to decrease 
until the 18th postoperative day. The further course of 
the GPT profiles differed considerably from dog to dog. 
However, more hectic profiles were seen in transplanted 
dogs and complete longstanding normalization of the GPT 
levels was noted in only a few of the control dogs. 
Table 5. Serum GPT( IU/1). 
Transplantation group~ dogs dying before the l69th day. 
pre- postoperative days 
opera- 0 4 6 11 18 25 32 46 60 74 95 123 151 
tively 9 p.m. 9 a.m. 
T 1' 23 834 
2' 19 1229 1498 
3' 21 1298 2148 943 636 
4' 24 645 838 348 222 
5• 34 659 700 157 128 
6' 22 1357 1098 487 678 1200 
7• 29 1462 1680 642 384 124 125 471 246 
8 28 1054 928 403 252 210 86 583 429 
9 813 849 322 152 55 33 177 322 
10 914 909 497 274 209 172 191 342 297 329 313 230 117 
T =transplanted dogs *=first 10 experiments 
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Table 6. Serum GPT (I U/1). 
Transplantation group: dogs surviving for 169 days. 
T 11 * 
12• 
13• 
14 
15 
16 
17 
18 
19 
20 
pre- postoperative days 
opera- 0 4 6 11 18 25 32 46 60 74 95 123 151 
tively 9p.m. 9a.m. 
34 1410 834 550 277 86 38 66 34 426 1255 1426 477 271 953 
32 7CR 921 510 252 155 61 47 204 168 126 214 296 173 157 
25 706 727 309 288 124 44 65 65 204 60 102 26 33 
37 
26 
32 
21 
31 
24 
868 807 21 127 399 55 413 155 183 363 149 155 490 722 
885 359 282 144 127 46 51 52 68 24 55 so 100 
450 522 
487 608 201 
649 655 303 
374 46 31 171 120 388 842 449 738 345 156 
105 63 92 65 74 63 58 289 30 
136 51 26 60 465 220 154 251 263 139 226 
447 568 304 181 66 363 407 398 369 190 380 393 151 64 
115 115 159 82 25 52 213 207 102 60 66 35 45 
T ==transplanted dogs *=first 10 experiments 
Table 7. Serum GPT (IU/1). 
Control group. 
pre- postoperative days 
Cl 
7 
8 
9 
10 
opera- 0 4 6 11 18 25 32 46 60 74 95 123 151 
tively 9p.m. 9a.m. 
26 
32 
42 
18 
28 
30 
16 
20 
32 
100 
591 5CR 449 496 136 45 
477 594 291 104 77 30 
169 183 131 72 26 B 
129 212 83 70 186 110 
311 417 777 898 202 47 
518 485 219 110 163 97 
326 325 143 91 46 24 
276 322 104 11 28 15 
332 408 170 78 44 24 
70 50 1345 170 832 560 174 119 
48 30 844 1606 1321 430 733 493 
20 19 39 30 117 73 14 55 
120 437 108 101 273 249 88 
24 25 26 38 50 71 82 91 
47 47 78 41 54 116 261 
34 26 30 24 28 33 20 371 
530282224242347 
42 37 58 27 38 16 19 25 
C = control dogs *=first 5 experiments (with immunosuppressive treatment) 
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The serum alkaline phosphatase levels started to rise 
after the completion of the operation. The highest values 
were usually measured on the 4th or 6th postoperative 
day, after which the levels usually declined 
progressively until the 18th or 25th day. The further 
course of these profiles also differed considerably from 
dog to dog and was usually more abnormal in transplanted 
dogs. 
Table 8. Serum alkaline phosphatase (IU/1). 
Transplantation group: dogs dying before the 169th day. 
pre- postoperative days . 
opera- 0 4 6 11 18 25 32 46 60 74 95 123 151 
tively 9 p.m. 9 a.m. 
T 1• 110 398 
2• 133 114 238 
3• 103 213 948 6607 5208 
4• 60 88 323 3978 5868 
5• 109 135 495 2576 311 
6• 81 214 627 1941 
7• 78 98 196 414 376 207 263 613 486 
8 60 62 178 1065 752 1189 671 1793 1822 
9 124 242 504 494 416 274 696 9350 
10 183 856 9240 7188 5346 3100 2381 2409 2646 2192 1886 1435 lll J 
T = transplanted dogs *=first 10 experiments 
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Table 9. Serum alkaline phosphatase (lU/1). 
Transplontatian group: dogs surviving for 169 days. 
pee 
opera- 0 4 6 11 
postoperative days 
18 25 32 46 60 74 95 123 151 
tively 9p.m. 9a.m. 
T11' 92 87 
12* 115 150 
13. 241 140 
14 127 64 
15 162 167 
16 88 156 
17 66 62 
18 153 
19 131 151 
20 87 186 
T"" transplanted dogs 
289 706 596 388 201 189 138 935 8 J 02 
266 244 237 2169 1200 572 827 560 523 751 974 678 356 
279 1719 1953 1030 468 331 464 675 631 424 54 241 
62 338 320 323 401 859 731 905 1301 522 554 1017 567 
7 42 1459 1512 1097 478 387 289 256 330 242 470 452 1377 
252 2450 246 224 598 539 878 1186 124 1153 935 478 
192 809 654 456 304 209 148 56 95 272 84 
840 1063 882 3194 2454 6380 6646 4873 6695 6556 6526 6843 
88 2734 2034 1320 1399 1409 1457 2182 1039 1214 328 200 
864 1731 512 245 243 295 173 205 115 52 69 
*=first 10 experiments 
Table 10. Serum alkaline phosphatase ( IU/1). 
Control group. 
postoperative days pre-
opera- 0 4 6 11 18 25 32 46 60 74 95 123 151 
tively 9p.m. 9a.m. 
C1 57 65 
2' 114 144 329 353 369 612 385 267 255 2206 704 837 871 501 265 
3' 103 125 343 513 277 291 185 160 139 949 940 3037 1272 1576 492 
4• 
5' 
6' 
75 
188 
163 
131 168 1555 1144 462 219 158 156 387 160 
223 322 226 221 392 286 307 338 284 233 
166 515 3810 3509 1642 626 382 266 221 463 
153 135 108 115 
246 211 168 
239 266 330 305 
7 106 153 386 1852 1140 749 442 234 159 435 102 93 773 412 4123 
8 179 447 205 205 242 321 211 302 185 175 165 192 193 3144 
9 
10 
111 140 285 549 428 238 
261 426 2012 4437 1763 
157 161 123 
626 307 271 
112 116 
349 200 
100 
140 
103 115 
103 
172 
123 
C = control dogs *=first 5 experiments (with immunosuppressive treatment) 
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Serum albumin 
The serum albumin levels are given in Tables 11, 12, 
and 13. The decrease seen during surgery was corrected to 
a large extent postoperatively, and reasonable levels 
were maintained in dogs that survived the study period, 
at least in the absence of overt morbidity. 
Tobie 11, Serum albumin ( g/1). 
Transplantation group: dogs dying before the 169th day. 
pre- postoperoti ve days 
opera- 0 4 6 11 18 25 32 46 60 74 95 123 151 
tively 9 p.m. 9o.m. 
T 1• 42 26 
2• 35 36 
3• 35 25 28 30 
4• 41 30 33 37 
5• 36 28 36 27 20 
6• 42 30 34 37 25 
7• 41 34 35 38 37 36 38 39 
8 40 32 33 25 25 29 
9 31 35 34 35 38 36 38 
10 46 25 30 27 26 29 37 36 37 35 35 35 37 
T = transplanted dogs *=first 10 experiments 
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Table 12. Serum albumin (g/1). 
Transplantation group: dogs surviving for 169 days. 
pre-
opera- 0 4 
tively 9 p.m. 9 a.m. 
T 11 * 42 
12* 32 
13* 36 
14 38 
15 40 
16 39 
17 39 
18 
19 
20 40 
27 29 32 
28 29 32 
30 29 29 
25 28 35 
27 31 39 
31 29 31 
31 32 32 
30 31 34 
35 33 
28 36 33 
mean 38.2 28.5 30.9 33.0 
SD 3.0 2.0 2.7 2.6 
postoperative days 
6 11 18 25 32 46 60 74 95 123 151 
35 40 39 39 34 33 
28 32 36 38 38 37 
34 37 37 37 36 37 
36 38 38 38 40 
36 37 34 42 42 
36 36 35 38 40 38 
33 36 39 35 37 
41 26 28 34 30 28 
34 37 37 38 38 
34 35 36 37 43 
34 
38 
37 
40 
30 
35 
30 
41 
29 23 
36 37 
35 35 
39 43 
31 38 
37 
36 
39 27 
36 37 
39 33 
28 
33 
36 
40 
39 
23 
31 
34.7 35.2 35.6 37.1 36.6 37.3 35.6 35.7 34.1 32.8 
3.2 4.1 3,3 1.7 3.7 4.3 4.1 3.3 6.4 6.0 
T =transplanted dogs *=first 10 experiments 
Table 13. Serum albumin ( g/1). 
Control group. 
pre-
opera- 0 4 
tively 9p.m. 9a.m. 
C1 30 33 
2* 43 
3* 37 
4* 38 
5* 36 
6* 37 
7 38 
8 38 
9 
10 
34 34 33 
27 29 29 
31 34 30 
32 33 31 
29 25 29 
32 42 29 
16 11 29 
35 33 29 
30 25 27 
mean 37.1 29,929.5 29.5 
SD 3.5 5.4 8.6 1.6 
C = control dogs 
postoperative days 
6 11 18 25 32 46 60 74 95 123 151 
n ~ 39 v 36 • 35 • w v 
~ • • v ~ 35 v v w ~ 
36 ~ w ~ ~ ~ ~ v 36 v 
n v v 36 35 ~ u w M • 
30 33 35 36 36 34 34 35 36 31 
m u u v v w ~ u u ~ 
M ~ ~ v ~ w • ~ 41 e 
32 ~ ~ W ~ • W M 
31 36 35 37 39 35 34 
32.7 35.3 37.2 36.3 36.5 35.2 36.0 37.5 37.5 35.3 
2.7 2.6 2.1 0.7 1.8 4.2 1.6 2.0 3.4 2.1 
*=first 5 experiments (with immunosuppressive treatment) 
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Bromsulphthalein and antipyrine handling 
The half-life values for both substances are given in 
Tables 14-16 and 17-19, respectively. As could be 
expected, the half-life values for bromsulphthalein were 
increased in jaundiced animals. In dogs which survived 
for the entire period of the study, the bromsulphthalein 
handling was maintained well, although temporary 
increases above a value of four minutes were sometimes 
seen in the absence of jaundice. 
Table 14. Bromsulphthalein (~ in minutes). 
Transplantation group: dogs dying before the J69th day. 
pre- postoperative days 
opera- 0 4 6 ll 18 25 32 46 60 74 95 123 151 
tively 
T 1• 3.2 
2• 3,1 
3• 3,3 5,5 
4• 3.0 11.4 
5. 3.2 3.6 
6• 3,0 18.0 
7• 3.2 5.2 3,6 
8 3,3 8.8 4.0 
9 3,1 4.5 3.4 >30.0 
10 3.2 8.8 3.4 4.0 4.0 3.6 3.5 
T = transplanted dogs *""first 10 experiments 
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Table 15. Bromsulphthalein (t~ in minutes). 
Transplantation group: dogs surviving for 169 days. 
pco postoperative days 
opera- 0 4 6 11 18 25 32 46 60 74 95 123 151 
tively 
T 11* 3.2 3.2 3.2 3.5 3.6 16.6 24.4 21.0 14.1 
12• 3.5 4.6 3.3 3.8 6.2 3.3 4.8 
13• 3.2 4.2 3.4 3.3 3.4 3.0 3.4 3.0 3.2 
14 3.2 4.1 4.2 4.5 3.2 3.8 5.0 3.3 3.1 
15 3.2 4.2 3.4 3.0 3.1 3.4 3.3 3.3 3.3 
16 3.4 3.8 3.2 3.6 3.4 4.2 3.1 3.0 3.2 
17 3.4 3.7 3.3 3.5 3.9 3.2 3.8 3.5 3.6 
18 3.3 4.0 13.1 5.3 3.8 5.3 6.4 16.4 
19 3.0 4.5 4.4 5.7 3.4 3.9 3.3 3.9 3.6 
20 3.0 3.8 3.2 3.0 3.2 3.2 3.1 3.3 
T"' transplanted dogs *""first 10 experiments 
Table 16. Bromsulphthalein (~in minutes). 
Control group. 
pre- postoperoti ve days 
opera- 0 4 6 11 18 25 32 46 60 74 95 123 151 
tively 
c 3.2 
2• 3.2 3.2 3.6 5.7 5.0 5.4 5.7 3.2 3.4 
3• 3.3 3.8 3.6 4.8 17.0 3.6 8.6 4.1 3.3 
4• 3.0 4.0 3.4 3.3 3.3 3.2 3.5 4.2 2.9 
5• 3.5 3.6 3.5 3.0 2.8 3.2 3.0 3.0 3.5 
6• 3.0 3.3 3.4 3.5 3.2 3.3 3.0 3.0 3.0 
7 3.3 5.0 4.0 3.1 3.3 3.0 3.4 8.9 8.0 
8 2.9 3.7 3.2 3.0 3.4 3.4 3.0 3.1 
9 3.0 3.0 3.1 2.8 3.1 3.5 3.0 3.1 3.0 
10 2.8 3.3 3.3 3.3 3.1 3.2 3.0 2.9 
C "" control dogs *"'first 5 experiments (with immunosuppressive treatment) 
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The preoperative half-life values for antipyrine 
varied considerably, but the mean values for the control 
group remained about the same throughout the survival 
period. In contrast, the transplantation group showed a 
considerable decrease of the half-life values 
postoperatively and these lowered values persisted in 
surviving dogs until after the 74th postoperative day. 
Later, the values rose in this group. 
Table 17. Antipyrine ( t! in minutes). 
Transplantation group: dogs dying before the 169th day. 
pre- postoperative days 
opera- 0 4 6 II 18 25 32 46 60 74 95 123 151 
tively 
T I • I 19 
2• 88 
3• 92 71 
4• 136 61 
5• 127 91 
6• 160 84 
7• 117 77 118 
8 90 89 112 
9 129 91 89 192 
10 110 106 74 66 
T "' transplanted dogs *=first JO experiments 
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Table 18. Antipyrine ( t1: in minutes). 
Transplantation group: dogs surviving for 169 days. 
pre-
opera- 0 
tively 
T 11* 132 
12* 67 
13* 72 
14 68 
15 88 
16 79 
17 76 
18 94 
19 91 
20 76 
mean 84 
SD 19 
T =transplanted dogs 
4 
73 
64 
72 
60 
73 
74 
65 
73 
63 
65 
68 
5 
6 11 
Table 19. Antipyrine ( t1: in minutes). 
Control group. 
pre-
opera- 0 
tively 
c 1 135 
2* 110 
3* 86 
4* 72 
5* 90 
6• 99 
7 100 
8 81 
9 54 
10 56 
mean 
SD 
88 
24 
4 
114 
81 
71 
69 
85 
110 
78 
65 
84 
18 
6 11 
postoperative days 
18 25 32 46 60 74 95 123 151 
86 
75 
80 
71 
75 
78 
81 
82 
78 
4 
94 86 
83 71 
76 72 
72 69 
59 63 
71 77 
79 100 
80 73 
75 103 
76 79 
9 14 
71 78 
65 
73 69 
65 68 
73 68 
63 49 
69 65 
74 77 
88 77 
80 80 
72 70 
7 9 
*=first 10 experiments 
postoperative days 
123 131 
72 
78 107 
74 80 
90 126 
72 84 
81 82 
112 161 
121 90 
86 90 
93 102 
20 28 
18 25 32 46 60 74 95 123 151 
124 
72 
88 
80 
131 
94 
71 
67 
68 
88 
24 
105 107 84 93 
74 85 93 91 
82 77 74 78 
85 101 72 73 
88 109 102 88 
125 107 95 112 
84 77 88 89 
69 80 73 53 
66 81 76 
86 90 84 
18 15 lT 
78 
83 
16 
88 76 
72 62 
79 102 
67 67 
87 81 
107 124 
68 106 
85 73 
100 90 
83 86 
13 20 
C = control dogs *=first 5 experiments (with immunosuppressive treatment) 
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l0e3. Discussion 
None of the 20 transplanted and 10 control dogs died 
during surgery, and there was only one death due to acute 
liver failure within the first week after surgery. In the 
event of massive ischemic damage to the liver, the dog 
dies within a few 
a~ 
hours after surgery from 
liver outflow block.6 
acute liver 
Persistent insufficiency 
bleeding, hypoglycemia, hyperkalemia and 
hyperbilirubinemia form part of the picture. 6 ' 7 Clinical 
liver outflow block was not observed in this series of 
experiments, and pathological bleeding, though constantly 
present during surgery, was not uncontrollable. 
Symptomatic hypoglycemia only occurred in the dog which 
died from acute liver failure. In 27 of the 29 other 
dogs, the blood sugar level remained above 3 mmol per 
liter. 
Postoperative serum potassium concentrations higher 
than 6 mmol per liter were not observed. In contrast, 
there was a tendency toward early postoperative 
hypokalemia. This phenomenon is considered to be an early 
postoperative manifestation of liver function, because it 
indicates that the intracellular potassium content has 
been restored after depletion due to ischemia. 7 
An early postoperative rise of the total serum 
bilirubin level above 10 urnol per liter usually indicated 
biliary-tract pathology. A slight temporary rise of the 
levels during the first 24 hours was, however, a common 
finding in the first 15 experiments, even in the absence 
of obvious biliary-tract pathology, and may be a 
manifestation of ischemic damage to the liver. This is 
supported by the fact that the postoperative increase of 
the serum GPT levels was also more pronounced in these 
experiments. The aminotransferases are known to be 
sensitive indicators of hepatic injury.l,3 The whole 
cooling and preservation procedure was therefore checked 
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critically. It was found that the refrigerator used for 
storage of the preservation fluids and the livers was 
only maintaining a temperature of 10°C at its minimal 
setting and that the 
obtain a temperature 
maximum setting was 
of 4°C. This change in 
required to 
the storage 
temperature may well explain why early increases of total 
serum bilirubin became rare during the second 15 
experiments and why the GPT rises became less pronounced. 
However, the rise of GPT remained more marked in the 
transplantation group, which is not surprising in view of 
the much longer total ischemic time to which the livers 
in this group were exposed. 
Eight of the deaths in the pres·ent series occurred 
after one week and 5 were clearly related to technical 
complications. Chronic liver failure was only the cause 
of death in one case, a dog in the transplantation group 
which was killed because of this condition on the 39th 
day. An atrophied graft was found at autopsy. Histology 
revealed multilobular necrosis and local purulent 
cholangitis but no rejection. 
In the 10 transplanted and 9 contol dogs which 
survived for the entire period the liver obviously 
functioned well enough to sustain life that long. In the 
majority of these dogs the 
excellent, as can be 
quality of 
deduced 
life was 
from the 
clinically 
over-all 
body-weight changes. In the survivors the synthesis of 
albumin and handling of brornsulphthalein were well 
preserved, at least in the absence of overt morbidity. 
Measurement of the serum albumin levels provides a guide 
to the severity of chronic liver disease, 3 and the 
bromsulphthalein test is considered to be a sensitive 
indicator of liver function in the absence of 
jaundice.l-3 The microsomal function of the liver, as 
reflected by the half-life of antipyrine, 2 ' 3 also was 
well preserved. While the mean half-life values remained 
relatively constant in the control group, lowered values 
persisted postoperatively in the transplantation group 
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until after the 74th day. This could be explained as a 
steroid effect. 3 However, this phenomenon, was not 
observed in the five control dogs, which were on the same 
immunosuppressive regimen. 
The first part of this discussion has dealt with the 
positive aspects; the second part concerns the 
shortcomings. Although usually not lethal,hepatic damage 
always occurred. The tendency to develop early 
postoperative hypokalemia although not a bad prognostic 
sign, as well as the early rise of the GPT and alkaline 
phosphatase levels, are expressions of hepatic damage. 
The difference between the transplantation and control 
groups, with respect to the magnitude of the early 
postoperative rise of the levels of the enzymes in 
question indicates that the liver grafts were more 
severely damaged than the livers in control dogs. This is 
not surprising in view of the difference between the two 
groups as to the total ischemic time of the liver. 
The restlessness of the GPT and alkaline phosphatase 
profiles in the dogs surviving for the entire study 
period is worrying, as is the late increase in the 
half-life values for antipyrine in the transplantation 
group. One wonders what would have happened if the study 
period had been 
between the 
percutaneous 
longer. No clear relationship was found 
restlessness of these profiles and the 
biopsy procedures. The transanastomotic 
biliary splint may, however, have contributed to these 
events by causing intermittent obstruction and recurrent 
ascending cholangitis. Microbiological screening might 
have given more information, but unfortunately was not 
included in the protocol. 
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10.4. Conclusions 
After revascularization, all of the livers showed 
biochemical evidence of damage, and this was more 
pronounced in the transplantation group. Nevertheless, 
all but one of the livers were able to sustain life 
during the early postoperative period, and late liver 
failure occurred only once as a primary cause of death. 
The remaining 9 dogs died from other causes. 
Most of the 19 dogs which survived the entire study 
period had a good quality of life. Although the liver of 
these dogs was able to synthetize albumin and to handle 
bromsulphthalein and antipyrine reasonably well, the 
fluctuating enzyme profiles indicated that hepatic damage 
occurred repeatedly during the survival period. The 
transanastornotic biliary splint may well have been 
co-responsible for this. 
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CHAPTER ll. PATHOLOGY OF THE LIVER 
ll.l. Methods 
ll.l.l. Sampling 
Three wedge biopsies were performed peroperatively: 
the first sample was taken from the left lateral lobe of 
the liver immediately after entering the abdomen of donor 
and control dogs, the second from the left medial lobe of 
the same liver at the end of the preservation period, and 
the third from the right medial lobe of the same liver 
after revascularization. The wedges were cut with a pair 
of scissors, the first and last under digital compression 
of the part of the liver to be biopsied, to prevent loss 
of blood. Compression was maintained until the cut 
surfaces of the organ had been electrocoagulated. 
Percutaneous biopsies were carried out on the 8th, 
22nd, 43rd, 85th, and !26th days after surgery, with a 
Menghini-type needle (HepafixR,l.6 mm in diameter, 90 mm 
long, and with a sleeve length of 20 rnrn). The dogs were 
starved overnight before the procedure. As sedative, 
fluanisone was given i.m. in a dose of 3 mg per kg. The 
dogs were placed in a supine position, and the needle was 
introduced subcostally on the right side above the 
laparotomy scar, at a point lying on the nipple line, and 
was advanced in a vertical plane upward and posteriorly 
at an angle of 45°. At most 3 punctures were perforrned 
per session. 
Final samples were taken at autopsy. All autopsies 
were performed within 18 hours after the last time the 
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dog had been seen alive. In dogs that were killed, fresh 
material was taken. After removal of the liver, all lobes 
were transected through the largest diameter. A biopsy 
specimen was routinely taken from the right lateral lobe. 
Additional samples were taken from other areas of the 
organ if differences in pathology were suspected. 
11.1.2. Processing of the samples 
All specimens were divided into three parts, one of 
which was immersed in formalin for routine histological 
assessment, one in liquid nitrogen for 
glutaraldehyde 
immunofluorescence 
for electron-studies, and one in 
microscopy. The first was then embedded in paraffin and 
sections were stained with haemotoxylin and azoflavin; 
haemotoxylin, azoflavin and saffran; Gomori's reticulin 
stain; periodic acid Shiff (PAS); PAS after pretreatment 
with diastase (D/PAS); Perl's iron stain; and the 
Gieson-Lawson elastin stain. The other two parts were not 
routinely examined but stored for further analysis in 
case routine histological assessment indicated a need for 
that. In this context only one post-revascularization 
biopsy specimen was 
microscopically. 
additionally analysed electron-
11.2. Results 
11.2.1. Methods of sampling 
No complications associated with the peroperative 
sampling were seen. Of the 
liver biopsies ,62 were in the 
total of 105 percutaneous 
transplantation group and 
transplanted dog died from a 
the !27th postoperative day, 
43 in the control group. One 
peripheral bile-duct leak on 
one day after a percutaneous biopsy had been performed. 
There were no other obvious complications, but the tissue 
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collected was often fragmented and included few portal 
fields. It was therefore impossible to draw definite 
conclusions 
unfortunate 
regarding the portal fields, 
because the most important 
which is 
pathological 
changes in the liver of long-term survivors concerned the 
portal fields. 
11.2.2. The microscopical findings 
The first biopsy specimen of two dogs already showed 
pathological 
infiltrate 
transplanted 
changes. A 
was found 
dog and 
dense 
in the 
polymorphonuclear-cell 
portal fields of a 
moderate mononuclear-cell 
infiltration without invasion of the bile ducts was seen 
in the portal fields of a control dog. 
All post-revascularization biopsy specimens showed 
signs of congestion, albeit varying in intensity from 
liver to liver. Liver cells adjacent to strongly dilated 
sinusoids had a compressed appearance and an angular 
shape. Other liver cells had an edematous appearance. 
Accumulation of fat droplets in the mid-sinusoidal liver 
cells was noted in about 40% of the transplanted livers 
but was rare in the livers of control dogs. Liver-cell 
necrosis was seen in only one dog (T 2). The necrosis in 
this dog was minimal and restricted to the peri central 
area. Glycogen depletion was seen in all livers; the 
degree varied from liver to liver, but was greater in the 
transplantation group. The sinusoids contained an 
increased number of polymorphonuclear cells. The activity 
of Kupffer cells had increased and many of these cells 
contained inclusions which stained positively with PAS 
after pretreatment with diastase. Another consistent 
finding in the post-revascularization biopsy specimens 
was the intrahepatocellular presence of smooth 
homogeneous bodies of different sizes which stained 
positively with PAS after pretreatment with diastase 
(Fig. 1). Electron-microscopically, these bodies were 
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homogeneously black and had no surrounding membranes 
(Fig. 2). Marked swelling of the mitochondria was also 
seen electron-microscopically. Light-microscopically, the 
portal areas appeared normal except that the cells of the 
epithelium of the smaller bile ducts were no longer 
cuboidal but had become high-cylindrical and showed basal 
vacuolization. 
Fig. l. Biopsy specimen of a liver graft, token shortly after revascularizotion. Hepatocytes with 
inclusion bodies in the cytoplasm ore clearly visible (PAS stain after pretreatment with 
diastase, x 250 ). 
Fig. 2. Electron-micrograph (x 16,000) of the same biopsy specimen showing part of o hepatocyte 
with a nucleus and on inclusion body (arrow). (Courtesy of V. D. Vvzevski. M.D.). 
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In view of the differences in survival duration for a 
considerable number of the dogs, a short description of 
the microscopical 
given for each 
appearance of the liver at 
animal. Three groups of 
autopsy is 
dogs are 
considered: group A, in which death occurred within 24 
hours; group B, in which death occurred later than 24 
hours; and group C, in which the animals were still alive 
at the end of the study period. The macroscopic autopsy 
findings are given in Chapter 7. 
Group A: Microscopical appearance of the liver at 
autopsy in dogs which died within 24 hours after the 
operation (n = 3). 
T 1 (survived 8 hr, died of air embolism): 
Over-all architecture intact. The hepatocytes are 
angular and the cytoplasm is dark and eosinophilic. 
Bodies showing D/PAS positivity have disappeared 
from liver cells. Extensive hemorrhagic areas are 
present in the parenchyme, especially around the 
portal fields. Polymorphonuclear ~lls have 
accumulated in the sinusoids. Kupffer cell activity 
is slightly increased. Almost no signs of 
inflammatory cell infiltration are seen in the 
portal areas. The bile-duct epithelium is of the 
high-cylindrical type and is vacuolated basally. 
Conclusion: hepatic tissue showing marked signs of 
ischemia. 
T 2 (survived 24 hr, died of hypoglycemia): 
Over-all architecture intact. Marked signs of acute 
congestion. The hepatocytes still contain inclusion 
bodies. Severe glycogen depletion is noted. 
Conclusion: acute congestion of the liver. 
C 1 (survived 16 hr, killed because of neurological 
damage secondary to an anesthetic accident): 
Over-all architecture intact. There are signs of 
acute congestion. No intrahepatocellular inclusion 
bodies are seen. Kupffer cells loaded with D/PAS + 
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stained material are scattered throughout the 
sinusoids. The portal veins are dilated. The bile 
duct epithelium is high cylindrical and is 
vacuolated basally. 
Conclusion: acute congestion of the liver. 
Group B: Microscopical appearance of the liver at 
autopsy in dogs dying later than 24 hours after the 
operation (n = 8). 
T 3 (survived 8 days, died of biliary peritonitis): 
Over-all architecture intact. There are signs of 
congestion. Kupffer cells loaded with D/PAS + 
stained material and some iron pigment are scattered 
throughout the sinusoids. The portal veins are 
dilated. The 
high-cylindrical 
bile-duct epithelium is of the 
type and is vacuolated basally. 
Glisson 1 S capsule is thickened and infiltrated by 
polymorphonuclear cells. 
Conclusion: congestion of the liver and peritonitis. 
T 4 (survived 9 days, died of biliary peritonitis): 
Over-all architecture intact. The sinusoids are 
dilated. Pericentral hepatocytes show necrosis. More 
remote hepatocytes are angular shaped and have 
cytoplasm with an eosinophilic appearance. 
cells lie Accumulations of polymorphonuclear 
scattered in the sinusoids. There are increased 
numbers of Kupffer cells 
material. The portal 
containing 
fields are 
D/PAS + stained 
enlarged by 
fibrosis, but cellular infiltration is absent. The 
portal veins are dilated. 
thickened and 
cells. 
infiltrated 
Glisson's capsule is 
by polymorphonuclear 
Conclusion: congestion of the liver with pericentral 
necrosis, peritonitis. 
T 5 (survived 11 days, died of a bleeding duodenal 
ulcer): 
Over-all architecture intact. Signs of acute 
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T 
congestion with pericentral necrosis. Kupffer cells 
loaded with D/ PAS + stained material are scattered 
throughout the sinusoids. Some fibrosis is often 
seen in the portal fields. The bile ducts have a 
high-cylindrical type of epithelium with basal 
vacuolization. 
Conclusion: 
necrosis. 
(survived 
acute congestion with peri central 
l4 days, died of hepatic artery 
thrombosis): 
Over-all architecture intact. Extensive pericentral 
necrosis. Extensive cholestasis. The sinusoids 
contain Kupffer cells loaded with D/PAS + stained 
material 
appear 
and some iron pigment. The 
The bile 
portal fields 
ducts have a almost 
high-cylindrical 
vacuolization. 
normal. 
type of epithelium with basal 
Conclusion: 
cholestasis. 
strong signs of ischemia, secondary 
T 7 (survived 32 days, died of biliary peritonitis): 
Autopsy material lost; no data available. 
T 8 (survived 37 days, killed because of poor general 
condition): 
The biopsy specimen taken from the right liver lobe 
shows an intact over-all architecture. There are 
signs of extensive congestion and pericentral 
liver-cell necrosis. The hepatocytes contain some 
iron and occasionally also bile pigment. The 
sinusoids have been invaded by polymorphonuclear 
cells and Kupffer cells loaded with D/PAS + stained 
material and iron pigment. The portal fields do not 
show any 
epithelium 
vacuolated 
taken from 
necrosis. 
cellular infiltrate. The bile-duct 
is of the high-cylindrical type and is 
basally. The additional biopsy specimens 
the central lobes show extensive 
Conclusion: congestion with signs of pericentral 
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necrosis in the right lobes and extensive necrosis 
in the central lobes. 
T 9 (survived 39 days, killed because of liver failure): 
Liver tissue shows multilobular necrosis. Numerous 
Kupffer cells, loaded with D/ PAS +stained material 
and iron pigment are seen in the necrotic areas. The 
portal fields are enlarged by fibrosis and show a 
polymorphonuclear-cell infiltrate which has 
occasionally reached and invaded the bile ducts. The 
bile-duct epithelium is of the high-cylindrical type 
and is vacuolated basally. 
Conclusion: multilobular necrosis of the liver with 
moderate fibrosis, local purulent cholangitis~ no 
eviQence of rejection. 
T 10 (survived 127 days, died of biliary peritonitis): 
Over-all architecture intact. Signs of severe 
congestion. The portal fields contain a few 
lymphocytes, but bile ducts have not been invaded. 
The bile-duct epithelium shows a tendency to 
stratification, and basal vacuolization is seen. 
Glisson•s capsule is thickened and infiltrated by 
polymorphonuclear cells. 
Conclusion: congestion, peritonitis; no signs of 
rejection. 
Group C: Microscopic appearance of the liver at 
autopsy in dogs still alive at the end of the 
study (n = 19). 
Ir~n~pla~t~tlo~ gr~uE 1n_=_lQ) 
T 11 (permanent jaundice after day 32): 
Over-all architecture intact. The hepatocytes have a 
feathery appearance and some are necrotic. Scattered 
accumrnulations of polyrnorphonucelear cells are seen 
in the sinusoids, and there is also an increased 
number of Kupffer cells loaded with D/PAS + stained 
material and sometimes also showing iron pigment. 
The portal fields are edematous and contain 
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T 12: 
T 13: 
T 14: 
polymorphonuclear and mononuclear cells as well as 
rnacrophages loaded with D/PAS + stained material. 
There is local invasion of the bile-duct epithelium, 
which shows a tendency to stratify and is vacuolated 
basally. 
Conclusion: 
septicemia. 
Over-all 
purulent 
architecture 
cholangitis, perhaps also 
intact. Sparse poly-
morphonuclear cells in the sinusoids. Kupffer-cell 
activity is low. Slightly increased fibrosis in the 
portal fields , which show slight infiltration of 
polymorphonuclear and mononuclear cells. Limited 
invasion of the high-cylindrical, basally vacuolated 
bile-duct epithelium. 
Conclusion: slight signs of cholangitis and perhaps 
of rejection. 
Over-all architecture intact. Signs of congestion 
and pericentral fibrosis. The sinusoids show very 
few polymorphonuclear cells. Kupffer cells loaded 
with D/PAS + stained material, are rare. The portal 
fields show some increased fibrosis and the portal 
veins are slightly congested. The bile-duct 
epithelium is predominantly of the high-cylindrical 
type and often vacuolated basally. The cellularity 
of the portal fields is minimal. 
Conclusion: signs of longstanding congestion but not 
of rejection. 
Over-all architecture intact. Small aggregates of 
polymorphonuclear cells are seen throughout the 
parenchyme. Scattered Kupffer cells loaded with 
0/PAS + stained material are also present. The 
portal fields are enlarged by fibrosis and contain a 
mixed polymorphonuclear- and mononuclear- cell 
infiltrate which sometimes invades the bile ducts. 
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The bile-duct epithelium is of the high-cylindrical 
type and is vacuolated basally. Bile-duct 
proliferation has occurred. 
Conclusion: cholangitis, perhaps minor signs of 
rejection. 
T 15 (temporary wound infection): 
T 16: 
T 17: 
Over-all architecture intact. The sinusoids contain 
polymorphonuclear cells, sometimes aggregated. 
Scattered Kupffer cells loaded with D/PAS + stained 
material and sometimes showing iron pigment. The 
portal fields show some fibrosis and infiltration of 
mixed polymorphonuclear and mononuclear inflammatory 
cells occasionally also invading the bile ducts. The 
bile-duct epithelium is of the high-cylindrical type 
and is vacuolated basally. 
Conclusion: minor signs of 
infectious component. 
Over-all architecture 
cells as well as Kupffer 
intact. 
cells 
rejection with an 
Polymorphonuclear 
loaded with D/PAS + 
stained material are found scattered throughout the 
sinusoids. Many portal fields are edematous and show 
fibrosis. A dense mononuclear-cell infiltrate is 
seen, occasionally invading the high-cylindrical, 
basally vacuolated bile-duct epithelium. 
Conclusion: 
rejection. 
portal hepatitis and cholangitis, 
Over-all architecture intact. The sinusoids contain 
a mixed polymorphonuclear- and mononuclear-cell 
infiltrate as well as scattered Kupffer cells loaded 
with D/PAS + stained material. The portal fields are 
enlarged by fibrosis. A small amount of cellular 
infiltrate is present, but invasion of the 
high-cylindrical, basally vacuolated bile-duct 
epithelium has not occurred. 
Conclusion: pericholangiolar fibrosis, aspecific 
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changes, no signs of rejection. 
T 18 (repaired biliary anastomotic leak, subphrenic 
abscess): 
T 19: 
T 20: 
Over-all architecture intact. Portal and periportal 
infiltration by mainly mononuclear cells. Invasion 
of the high- cylindrical, basally vacuolated 
epithelium is seen occasionally. Glisson•s capsule 
is thickened and there is a dense subcapsular 
infiltrate containing mixed polymorphonuclear and 
mononuclear cells. 
Conclusion: portal and periportal hepatitis, 
localized peritonitis, no signs of rejection. 
Over-all architecture intact. A few 
hepatocytes are 
D/PAS + stained 
sinusoids. The 
present. Kupffer cells 
degenerated 
loaded with 
material, are 
portal fields show 
found in 
lymphocytic 
the 
and 
plasmocytic cell infiltrate which has occasionally 
invaded the high-cylindrical, basally vacuolated 
bile-duct epithelium. Some fibrosis is seen around 
the bile ducts. 
Conclusion: minor signs of rejection. 
Same picture as in T 19. 
fOQt£Ol ~r~U£ in_=_9l 
c 2: 
Over-all architecture intact. The hepatocytes have a 
low glycogen content. A sparse mixed poly-
morphonuclear and mononuclear cell reaction is 
observed in the sinusoids. Kupffer cells loaded with 
D/ PAS + stained material are seen occasionally. The 
bile-duct epithelium is of the high-cylindrical type 
and is basally vacuolated. 
Conclusion: 
depletion. 
minor aspecific 
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changes, glycogen 
c 3: 
c 4: 
c 5: 
c 6: 
c 7: 
Same picture as in C 2, but without 
depletion. 
Conclusion: minor aspecific changes. 
Same picture as in C 3, but without 
infiltration of the sinusoids. 
Conclusion: minor aspecific changes. 
glycogen 
cellular 
Some fibrosis around the bile ducts. Sparse mixed 
polymorphonuclear- and mononuclear-cell infiltrate 
in the portal fields but no invasion of the bile 
ducts. 
Conclusion: minor aspecific changes. 
Over-all architecture intact. There is evidence of 
congestion. Some pericentral fibrosis. Sparse mixed 
cellular infiltrate in the sinusoids and portal 
fields. Scattered Kupffer cells loaded with D/PAS + 
stained material. The bile ducts occasionally show 
an invading lymphocyte and are often surrounded by 
fibrotic tissue. The epithelium is of the 
high-cylindrical type and is vacuolated basally. 
Conclusion: signs of longstanding congestion, minor 
cholangitis. 
Over-all architecture intact. Signs of congestion. 
The sinusoids contain a mixed cellular infiltrate 
and sparse Kupffer cells loaded with D/PAS + stained 
material. The cellularity of the portal fields is 
clearly 
seen to 
increased and of a mixed type 
have infiltrated the bile 
occasionally 
ducts. The 
epithelium is of the high-cylindrical type and is 
vacuolated basally. Some fibrosis is present around 
the bile ducts. 
Conclusion: 
cholangitis. 
signs of congestion, minor purulent 
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c 8: 
c 9: 
c 10: 
Over-all architecture intact. The sinusoids contain 
a low-grade mixed cellular infiltrate as well as 
scattered Kupffer cells loaded with D/PAS + stained 
material. The portal fields too show a low-grade 
mixed cellular infiltrate which has occasionally 
invaded the bile ducts. The epithelium is of the 
high-cylindrical type and is vacuolated basally. 
Conclusion: minor cholangitis. 
Over-all architecture intact. Some signs of 
congestion. Sparse mixed cellular infiltration in 
the sinusoids. Some Kupffer ce-lls loaded with D/PAS 
+ stained material. The bile ducts are locally 
surrounded by fibrotic tissue. The epithelium is of 
the high-cylindrical type and shows basal 
vacuolization. 
Conclusion: 
changes. 
some congestion, minor aspecific 
Over-all architecture intact. Kupffer cells loaded 
with D/PAS + stained material are seen in the 
sinusoids. The bile-duct epithelium is of the 
high-cylindrical type and basally vacuolated. 
Conclusion: minor changes. 
11.3. Discussion 
The method of sampling of the liver by wedge biopsies 
performed during the operation proved to be simple and 
without complications. Digital compression of the part of 
the liver to be biopsied, combined with electro-
coagulation of the cut surfaces, resulted in a bloodless 
procedure even in the presence of coagulopathy. 
The percutaneous-biopsy method for sampling of the 
liver proved unsatisfactory. The material obtained was 
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often fragmented and contained only a few portal fields. 
Since most of the relevant long-term microscopical 
changes concerned the portal fields, the percutaneous 
biopsy specimens had limited value for the assessment of 
long-term microscopical changes. 
Although liver outflow block did not appear to be a 
clinical 
specimens 
problem, all post-revascularization biopsy 
showed signs of sinusoidal congestion. 
Hepatocyte necrosis was rare, but accumulation of fat 
droplets in the hepatocytes of the middle zone was seen 
in about 40% of the transplanted livers. The combination 
of centrilobular sinusoidal congestion, 
hepatocyte necrosis, and accumulation of fat 
pericentral 
droplets in 
the hepatocytes of the middle zone, are 
histological features of liver outflow block in the 
known 
dog. 1 
It must therefore be concluded that some degree of liver 
outflow block always occurred, even in the control group. 
The lowered arterial diastolic bloodpressure in the 
postanhepatic period is consistent with this 
interpretation. The use of partial instead of total 
livers may well have been co-responsible for this 
phenomenon 
unreduced 
because the reduced livers received an 
Ali can 
portal venous supply after 
and Hardy 2 and Starzl et 
revascularization. 
relationship in dogs between the 
postulated a 
occurrence of liver 
outflow block and liver damage. Moreover the combination 
of liver damage with an augmented portal venous supply is 
known to promote the occurrence of liver outflow block.3 
The presence of intrahepatocellular inclusion bodies 
in the post-revascularization biopsy specimens is 
undoubtedly a preservation-related phenomenon, because 
these bodies were already present at the end of the 
preservation period. The responsible substance is neither 
glycogen nor fat, but the exact nature is not known. This 
phenomenon has not been described, but Krom has seen it 
in canine liver transplantation and very occasionally in 
human liver transplantation.4 It appears to be related to 
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the composition of the preservation fluid, but 
species-related differences also seem to play a role. The 
intrahepatocellular inclusion bodies disappeared rapidly. 
In two of the three dogs, whose death occurred within 24 
hours after the operation, no inclusion bodies were found 
in the autopsy specimen of the liver. In dog T 2, which 
died from acute liver failure, the inclusion bodies were 
still present in the autopsy specimen. The rapid 
clearance of these bodies therefore seems to be an 
expression of early hepatocellular function. 
The percutaneous biopsy specimens taken 8 days after 
the operation showed remarkable signs of recovery in the 
liver. The dilated sinusoids had largely disappeared and 
the shape of the hepatocytes had normalized. Hepatocyte 
necrosis was absent and the accumulation of fat droplets 
had disappeared. Moreover, glycogen storage had markedly 
improved, at least in dogs without overt morbidity in 
that stage. The intrahepatocellular inclusion bodies had 
also disappeared. Cellular infiltration of the portal 
areas was absent. The cells of the bile-duct epithelium 
were of a high-cylindrical 
vacuolization, and this 
type and showed 
feature was seen 
basal 
in all 
subsequent biopsy specimens. 
The microscopical appearance of the liver at autopsy 
of dogs succumbing before the end of the study was 
consistent with the diagnosed cause of death. Signs of 
acute congestion were often present but not clearly 
related to the degree of congestion found in the 
post-revascularization biopsies, which indicates a 
difference in etiology. The Kupffer cells invariably 
showed increased activity and loading with D/PAS + 
stained material. Polymorphonuclear cell infiltration the 
sinusoids was sometimes seen. The 
usually quite well preserved, 
intensification of fibrosis was seen, 
portal fields 
although 
especially 
were 
some 
around 
the bile ducts. Cellular infiltration of the portal 
fields was rare. 
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The over-all architecture of the liver, as seen in 
autopsy material from dogs still alive at the end of the 
study, was well preserved. Collapse of the connective 
framework was never observed, and necrosis of liver cells 
was rare. Signs of long-standing congestion were found in 
one transplanted 
polymorphonuclear-
and one control dog. A mixed 
and mononuclear-cell infiltrate was 
often seen in the sinusoids, especially in the 
transplantation group. The portal areas were frequently 
enlarged by fibrosis, and this was more pronounced in the 
transplantation group. Many portal areas showed cellular 
infiltration, and this too affected the transplantation 
group more severely. The cellular infiltrate was often of 
a mixed poly- morphonuclear- and mononuclear-cell type, 
but in the transplantation group the mononuclear-cell 
type predominated. 
Invasion of the bile-duct epithelium by mononuclear 
cells was seen in 6 transplanted dogs. In one control dog 
(C 6) an occasional lymphocyte had invaded the bile-duct 
epithelium as well. The cellular infiltrate found in the 
portal fields of this liver was, however, predominantly 
of the polymorphonuclear-cell type. Nonsuppurative 
destructive cholangitis is reported to occur frequently 
in human liver allografts and is considered to represent 
one component of allograft rejection.s Other histological 
features of chronic rejection such as cholestasis, foamy 
macrophages in the parenchyme, and vascular changesl,7 
were not seen. Many livers of the long-term survivors in 
both groups showed a polymorphonuclear-cell infiltrate in 
the portal fields, especially around the bile ducts. This 
phenomenon has also been observed in the livers of 
long-term survivors after experimental whole-liver 
autotransplantation, and has been ascribed to ascending 
cholangitis related to the presence of a cholecysto-
duodenostorny.l In the present series of experiments, 
however, we performed choledocho- choledochostomies 
instead of cholecysto- duodenostomies. The beneficial 
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effect of a sphincter-retaining anastomosis on the 
prevention of ascending cholangitis seems to have been 
eliminated by the use of a transanastomotic splint. 
Microbiological investigation might have supported this 
assumption, but 
protocol. 
unfortunately was not part of the 
11.4. Conclusions 
The method of the peroperative sampling of liver 
tissue by the performance of wedge biopsies proved to 
be simple and free of complications, whereas the method 
of percutaneous sampling led to the death of one dog. 
Moreover, the samples obtained percutaneously were often 
and included only few portal fields. fragmented 
Conclusive interpretation regarding these fields was 
therefore not possible, which is unfortunate because the 
most important pathological changes in the liver of 
long-term survivors concerned the portal fields. 
Signs of damage of the liver were seen in all 
post-revascularization specimens. At least some degree of 
congestion of the central veins and the pericentral 
sinusoids was always present, which indicates that some 
degree of outflow block had invariably occurred. The 
consistent finding of intrahepatocellular inclusion 
bodies raised questions about the preservation technique 
used. 
Irreversible damage to 
death, occurred in only 
the liver 
one dog. 
leading 
In this 
to early 
dog the 
intrahepatocellular inclusion bodies had not disappeared 
at autopsy. The other two early deaths had other causes, 
and early resumption of liver function in these dogs was 
suggested histologically by the rapid disappearance of 
the inclusion bodies. By the 8th day the liver had made a 
remarkable recovery. 
The histological findings in the samples taken at 
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autopsy of dogs whose death occurred before the 169th 
day, were 
The most 
consistent with the diagnosed cause of death. 
striking histological changes in the autopsy 
findings of long-term survivors concerned the bile ducts, 
especially the smaller ones, and the pericholangiolar 
portal tissue. Minor signs of rejection, defined as 
mononuclear-cell infiltration of the portal fields 
combined with invasion of the bile ducts, were present in 
6 transplanted dogs. Signs of moderate or severe 
rejection were never seen. The portal fields in both 
groups of dogs, however, often showed an increased number 
of polymorphonuclear cells, indicating the presence of an 
infectious agent. The possibility of a relation between 
this phenomenon and the use of a transanastomotic biliary 
splint must be taken into consideration. 
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CHAPTER 12. GENERAL DISCUSSION AND CONCLUSIONS 
If one decides to attempt to cure children with 
end-stage hepatic disease, one must resort to liver 
transplantation (Section 2.1). On the basis of current 
indications for liver transplantation, about 15 to 20 
children in The Netherlands will qualify for this 
procedure annually.l,2 The majority of these children 
will have biliary atresia as underlying disease. Although 
the hepatic porto-enterostomy has undoubtedly improved 
the short-term prognosis in children with biliary 
atresia, the majority of these children still progress to 
end-stage hepatic disease (Section 2.2). 
At present, it is logical to give preference to the 
orthotopic mode of liver transplantation, because this is 
the only mode which has given reasonably good results in 
man (Chapter 3). In children with biliary atresia, 
furthermore, it seems wise to remove the native liver at 
transplantation, in view of the time 
incidence 
of 
of recurrent cholangitis after 
the high 
hepatic 
porto-enterostomy,3 and the fact that incidental 
carcinomas have been found in the native livers of 
children with biliary atresia.4,5 
Until 1980, the over-all results of clinical 
orthotopic liver transplantation were not encouraging 
(Chapter 5). Since then, the one-year survival rate has 
doubled and is now about 70% in both children and 
adults.G Starzl et al. attribute this improvement mainly 
to the use of cyclosporin A and the concomitant reduction 
of the steroid dosage.6 However, other factors such as 
better recipient selection and improved techniques, 
especially for the biliary anastomosis, must also be 
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taken into accounte 7 
obtains roughly the 
imrnunosuppression.7,8 
The Groningen 
same results 
Nevertheless, 
team, for 
with 
example, 
classical 
cyclosporin A may 
prove to have 
transplantation 
special value 
by making it 
in pediatric 
possible to 
liver 
avoid 
steroid-induced growth retardation. 
There are still many problems to be solved in clinical 
orthotopic 
shortage 
liver transplantation (Chapter 4). The 
of donor livers and the 
organ-preservation time preclude 
selection on the basis of tissue typing. 
limited safe 
donor-recipient 
Due to the lack 
of an effective artificial liver and the limited supply 
and preservation time of donor livers, many patients are 
poor surgical risks. The operation itself is a formidable 
procedure, and interferes profoundly with hemodynamics 
and hemostasis. For many years the biliary anastomosis 
was the Achilles' heel of liver transplantation, but 
improvements in the techniques seem to have solved this 
problem to a great extent. Rejection was long believed to 
play a minor role in the poor results, but with the 
introduction of cyclosporin A the liver's status as 
immunoprivileged organ seems to have been weakened. 
Besides the effects of immunosuppressive therapy on 
the growth of children other problems too are encountered 
in pediatric liver transplantation. For example, there is 
the problem of the smallness of the size of the blood 
vessels, but this can be overcome by the use of 
microsurgical techniques.s Moreover, children with 
biliary atresia may have associated anomalies of the 
vascular supply of the liver.s,9 These anomalies will, 
however, be known beforehand, because at present all such 
children will have undergone hepatic porto-enterostomy. 
The most important special problem in pediatric liver 
transplantation is the shortage of size-matched donor 
livers. The use of the left lateral segment of adult donor 
livers, the adult donor livers being more readily obtain-
able may offer a solution to this problem {Chapter 1). 
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In man, removal of all but the left lateral segment of 
the liver has proven to be feasible, and there can be 
little doubt that a right hepatic trisegmentectomy will 
be easier to perform on a cooled human donor liver on the 
bench than in vivo. The human liver is, however, much 
less lobulated than the canine liver and more parenchyme 
will have to be transected. Biliary leakage and loss of 
blood from the amputation site are therefore more likely 
to occur in man, but can be avoided by meticulous 
ligation of all intraparenchymal vessels to be 
transected. 
From the results of the experimental study it can be 
concluded that it is technically feasible to transplant 
part of an adult liver orthotopically, at least under the 
experimental conditions applied. The preparation of the 
partial grafts on the bench proved simple and was not an 
important time-consumer. No mortality or morbidity could 
be attributed to the use of only part of the liver. Fifty 
percent of the dogs survived the 169-day period of the 
study, and most of these dogs did well clinically 
{Chapter 7). Bilirubin handling, albumin synthesis, and 
the clearance of both bromsulphthalein and antipyrine 
were reasonably well preserved (Chapter 10), Graft 
atrophy occurred in only one transplanted dog. In the 
transplanted dogs which survived the entire study period 
the weight of the graft had increased and equaled the 
weight of the removed native liver, despite the use of 
immunosuppressive drugs {Chapter 7). Comparison of the 
transplantation and control groups showed similar trends 
in the monitored items, although the changes were usually 
more pronounced in the transplantation group. No 
pronounced differences were found between immune-
suppressed and nonimmunosuppressed control dogs, but it 
must be acknowledged that these subgroups were small. 
The experimental series was not free of difficulties 
and problems, but these are also known to occur when 
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total livers are transplanted orthotopically. The 
surgical risk appeared to be related more strongly to 
insufficient decompression of the infradiaphragmatic 
venous systems during the anhepatic phase than to the 
hour-long absence of the liver (Chapter 8). Of special 
interest is the observation that the bleeding disorder 
started at the end of the anhepatic phase and that the 
course of this disorder appeared to be closely related to 
the changes in the platelet count rather than to the 
changes in the concentrations of coagulation factors. The 
advantages of decompression of the infradiaphragmatic 
venous systems during clinical liver transplantation are 
slowly gaining recognition, but mainly in connection with 
the hemodynamic status of the patient rather than any 
coagulation disorder. 10 Better decompression might have 
prevented the coagulation disorder observed. The present 
study shows clearly that glucose consumption does not 
increase during a one-hour anhepatic peroid, at least in 
healthy dogs. 
Although much attention was paid to the avoidance of 
damage to the 
1 i ver failure 
biochemically 
Moreover, the 
liver and although 
was rare, damage 
and histologically 
early postoperative 
did occur 1 as seen 
(Chapter 10 and 11). 
finding of intrahepatocellular inclusion 
bodies in the post-revascularization biopsy specimens 
raises doubts concerning the technique used for the 
preservation of canine livers (Chapter 11). 
As in clinical liver transplantation, anastomotic 
vascular problems were not a major cause of failure 
(Section 9.1). Pervenous angiography proved to be a very 
valuable tool for the diagnosis of such problems, as 
illustrated 
thrombosis. 
by the dog which developed 
The Achilles • heel of this 
hepatic artery 
study was the 
biliary reconstruction (Section 9.2). Especially worrying 
is the high incidence of splint-related complications. 
Moreover, the biliary splints may well have caused 
intermittent obstruction and recurrent ascending 
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cholangitis, which might explain the fluctuating liver 
enzyme profiles as well as the frequent finding of a 
polymorphonuclear-cell infiltrate and increased fibrosis 
around the bile ducts in the livers of the dogs autopsied 
at the end of the study period (Chapters 10 and 11). 
No signs of rejection were found in the dogs which 
died before the end of the study and only minimal signs 
were found in the transplanted dogs autopsied at the end 
of the study (Chapter 11)6 It may therefore be concluded 
that the measures taken to prevent and control rejection 
were effective. 
This experimental study has proven that it is 
technically feasible to transplant part of the donor 
liver orthotopically in dogs and that a partial liver 
graft can function adequately for a considerable period. 
The many problems encountered did not seem to be related 
to the use of only part of the donor liver or to 
rejection, but rather to defective preservation of the 
donor liver, insufficient decompression of the 
infradiaphragmatic venous systems during the anhepatic 
phase, and to an imperfect technique for the biliary 
reconstruction6 Therefore, further experimental work is 
undoubtedly required. 
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SUMMARY 
End-stage hepatic disease can only be cured by 
orthotopic liver transplantation. As pediatric surgeon, 
the writer of this thesis was interested in the problems 
that hamper the development of pediatric orthotopic liver 
transplantation. The shortage of size-matched donor 
livers for this purpose is a major problem. A possible 
solution would be the use of part of an adult donor 
liver, the adult organs being easier to obtain. The 
technical feasibility of this operation formed the basis 
of the experimental study described in the present thesis 
(Chapter l). 
Chapter 2 concerns the need for liver transplantation. 
At present, transplantation seems to be the only 
effective method available for the treatment of terminal 
liver failure (Section 2.1). The need for pediatric liver 
transplantation in The Netherlands and the most common 
indication for this treatment in the pediatric age group, 
i.e. biliary atresia, are discussed (Section 2.2}. 
A review of the various modes of liver transplantation 
led to the conclusion that only the orthotopic 
nonauxiliary mode has had clinical success (Chapter 3). 
The many problems associated with clinical orthotopic 
liver transplantation are analysed in Chapter 4. The 
shortage of donor livers and the limited safe 
preservation time of the organ as well as the usually 
poor preoperative general condition of the recipient, 
preclude optimal donor recipient selection. The biliary 
anastomosis has also been a major cause of mortality and 
morbidity. 
determinant 
Lastly, 
of the 
rejection seems to be an 
long-term prognosis of 
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important 
clinical 
orthotopic liver transplantation, and the human liver 
seems to be a less irnmunopriviliged organ than has been 
thought. 
The published results of clinical orthotopic liver 
transplantation in children are reviewed in Chapter 5. Up 
to 1980, the results were poor. The improvement achieved 
since 1983 is unquestionably related not only to the 
introduction of the new immunosuppressive agent, 
cyclosporine A, but also to the improved surgical 
techniques and to earlier recipient selection and 
transplantation. 
Chapter 6 describes 
discusses the choice 
the experimental 
of the experimental 
design, and 
animal, the 
handling of rejection, the reasons for the design of a 
control model and for the choice of the orthotopic mode 
of partial liver transplantation, the age of the 
experimental animals, the relative size of the grafts, 
the duration of liver ischemia, and the duration of the 
follow-up period. 
In Chapter 7 the surgical techniques are presented and 
the technical feasibility is described in terms of 
mortality, overt morbidity, and the autopsy findings. 
Chapter 8 focuses on the peroperative complications 
and the technical feasibility is assessed, in terms of 
surgical risk in the absence of peroperative mortality. 
Special attention was given to the postoperative 
monitoring of the patency of the various types of 
anastomosis. The methods used for and the results of 
monitoring are described and discussed (Chapter 9). 
The postoperative functioning of the liver was 
evaluated in terms of not only mortality and overt 
morbidity, but also biochemical homeostasis and handling 
of exogenous loading (Chapter 10). 
The quality of the liver after surgery was also 
followed histologically (Chapter ll). 
Chapter 12 gives a general discussion and the ensuing 
conclusions. 
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The question as to whether it is feasible to 
transplant part of a donor liver in an orthotopic 
nonauxiliary position, at least in dogs, is answered 
positively. 
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SAMENVATTING 
Terminale leverinsuffici~ntie kan enkel door middel 
van een orthotoop levertransplantaat curatief behandeld 
worden. Als kinderchirurg was de schrijver van dit 
proefschrift geinteresseerd in de problernen, die de 
toepassing van deze behandeling bij kinderen, in de weg 
staan. Een zeer belangrijk probleem is het nijpend tekort 
a an donor levers van aangepaste afrnetingen voor 
transplantatie 
dit probleem 
bij kinderen. Een mogelijke oplossing voor 
zou het gebruik van een deel van een 
volwassen donorlever kunnen zijn. Het aanbod van grote 
volwassen donorlevers is immers veel minder beperkt dan 
het aanbod van kleine kinderdonorlevers. Het 
experimenteel onderzoek naar de technische haalbaarheid 
van het transplanteren van een deel van een donorlever 
vormt de grondslag van dit proefschrift (Hoofdstuk 1). 
Hoofdstuk 2 handelt over de behoefte aan 
levertransplantatie. Eerst wordt nagegaan of er geen 
alternatieve effectieve methoden voor de behandeling van 
terminale leverinsuffici~ntie bestaan (2.1). Vervolgens 
wordt de behoefte aan levertransplantatie op de 
kinderleeftijd in Nederland onderzocht. Terminale 
leverinsuffici~ntie ten gevolge van galgangatresie is 
verreweg de meest voorkornende indicatie voor 
levertransplantatie op de kinderleeftijd (2.2). 
Uit het overzicht van de verschillende vormen van 
levertransplantatie, 
alleen de orthotope 
die werden toegepast, blijkt dat 
niet-auxiliaire vorm op dit ogenblik 
klinisch succes boekt (Hoofdstuk 3). 
Hoofdstuk 4 gaat in op de problemen waarmee men bij 
klinische orthotope levertransplantaties geconfronteerd 
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wordt. Door het tekort aan donorlevers, de beperkte 
preservatieduur 
conditie van 
donor-ontvanger 
ervan en de rneestal slechte preoperatieve 
de ontvanger, is geen optimale 
selectie rnogelijk. Bovendien hebben de 
problernen rand de galweganastornose een belangrijke 
invloed op de rnortaliteit en rnorbiditeit. Tenslotte 
blijkt rejectie van het transplantaat een belangrijkere 
rol te spelen bij de uiteindelijke prognose van klinische 
orthotope levertransplantatie dan voorheen gedacht werd. 
De resultaten van het orthotoop transplanteren van de 
lever bij kinderen worden in Hoofdstuk 5 besproken. Tot 
1980 waren deze resultaten bedroevend. De duidelijke 
verbetering, sedert 1983, is zeker niet alleen het gevolg 
van het gebruik van het nieuw immunosuppressivum, 
cyclosporine A, doch ook van de verbeterde chirurgische 
technieken en van de vroegtijdigere selectie en 
transplantatie van levertransplantatiekandidaten. 
Hoofdstuk 6 beschrijft het algerneen experirnentele 
antwerp met daarin aandacht voor de keuze van het 
proefdier, de aanpak van rejectie, de reden voor het 
cre~ren van een centrale model en voor het orthotoop 
niet-auxiliair transplanteren, de keuze van de leeftijd 
van het proefdier en van de relatieve grootte van de 
parti~le donor lever, de keuze van de duur van 
leverischemie en van de duur van de 
vervolgperiode. 
postoperatieve 
In Hoofdstuk 7 worden de chirurgische technieken 
beschreven en wordt technische haalbaarheid uitgedrukt in 
terrnen van rnortaliteit, klinisch duidelijke morbiditeit 
en autopsiebevindingen. 
In Hoofdstuk 8 wordt ingegaan op de peroperatieve 
cornplicaties en wordt technische haalbaarheid uitgedrukt 
in operatie-risico in afwezigheid van directe operatieve 
mortaliteit. 
De verschillende anastornosen werden postoperatief 
zorgvuldig ge~valueerd (Hoofdstuk 9). 
De functie van de lever na operatie werd niet alleen 
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nagegaan in termen van mortaliteit en morbiditeit doch 
ook in termen van biochemische homeostase en verwerking 
van exogeen toegediende substanties (Hoofdstuk 10). 
Tenslotte werd de kwaliteit van de lever na operatie 
microscopisch vervolgd (Hoofdstuk 11). 
Hoofdstuk 12 besluit het proefschrift met een algemene 
discussie en de uit het onderzoek te trekken conclusies. 
De vraagstelling of het orthotoop niet-auxiliair 
transplanteren 
bij honden, 
beantwoord. 
van een deel van een 
technisch haalbaar 
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donorlever, althans 
is wordt positief 
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